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Medical imaging is a crucial element that is interwoven in every step of the diagnosis and 
treatment of cancer, from early screening and staging, to therapeutic response assessment 
and post-treatment follow-up, where imaging findings can have a great impact on patient 
management and consequent outcomes. In current clinical practice, assessment is primarily 
qualitative, meaning that imaging examinations – e.g. computed tomography (CT), magnetic 
resonance imaging (MRI) or ultrasound (US) images – are visually interpreted by radiologists who 
report their findings using text reports. The main tools available to radiologists to “classify” their 
findings are visual classification systems such as the Tumor Node Metastasis (TNM) guidelines 
from the American Joint Committee for Cancer (AJCC) and tumor-specific staging systems such 
as the Breast Imaging Reporting and Data System (BIRADS) for breast cancer and the Prostate 
Imaging Reporting and Data System (PIRADS) for prostate cancer. 
However, there is much more information that can be extracted from medical images than 
meets the eye. Images are a collection of quantitative measurements, and consist of pixels 
which reflect the magnitude of some physical property in the small region covered by each 
pixel. Depending on the imaging modality used and the acquisition settings, multiple physical 
properties can be imaged, such as the tissue density on CT or the acoustic impedance on 
ultrasound. There are some simple “quantitative” tools that radiologists already commonly use 
to supplement their reports. Examples include tumor size measurements used in the Response 
Evaluation Criteria In Solid Tumors (RECIST) system for oncologic response assessment, or 
Hounsfield Units (HU) used to measure tissue density and enhancement characteristics on CT. 
However, these relatively simple methods of image quantification do not at all capture the full 
extent of information that is present in medical images. The magnitude and complex spatial 
distribution of pixel values within an image – commonly referred to as the image “texture” – can 
be used to study the underlying tissue architecture. In oncology, image texture has been shown 
to have the potential to assess intratumoral heterogeneity which in turn can be correlated to 
treatment outcomes and prognosis1,2. Though initial reports on image texture already date 
back to the early ‘70s3,4, there has recently been a renewed interest for texture analysis in 
medical imaging, in particular oncologic imaging. The re-introduction of the technique has 
been boosted by several recent advances. The development of novel imaging techniques such 
as diffusion-weighted MRI (DWI) and dynamic contrast enhanced (DCE) imaging has opened 
up a new array of functional imaging parameters reflecting biological tissue properties such as 
cellularity and perfusion. In addition, the exceptional growth in computational power and data 
storage has led to the digitization of medical image storage, making huge quantities of data 
easily available for analysis, which has consequently given rise to widespread use of artificial 
intelligence (AI) and its subfield, machine learning. 
In machine learning the computer uses algorithms to infer or ‘learn’ correlations from the 
data it is provided, aiming to predict a desired outcome and making optimum use of the large 
amounts of data and quantitative information provided by modern-day medical images. The 
process of extracting this information in the form of “features” to generate a radiographical 
tumor phenotype, and using this to construct predictive models using machine learning and AI 
is known as “radiomics”5. 
The process of radiomics comprises of four key steps, which are each associated with their 
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own specific challenges. The following sections discuss these four steps and highlight which 
challenges need to be overcome for radiomics to be successfully applied and implemented in 
oncologic imaging practice.
Key steps and challenges in the radiomics and AI workflow
 
1. Segmentation
Before quantitative features can be extracted from medical images, the computer needs to 
‘know’ which part of the image represents the region of interest (ROI). In oncology, the ROI will 
typically be the tumor under investigation or a specific organ harboring a malignancy. The most 
common method to define the ROI within an image is to ask a reader (often an experienced 
radiologist) to manually delineate or “segment” it, for example by tracing the boundaries 
of a tumor lesion on a slice-by-slice level. This is, however, both a labor-intensive and time 
consuming task which can suffer from substantial inter- and intra-reader variation that can 
affect extracted feature values6,7. There is thus an urgent need for (semi-)automatic tools to 
reduce the workload for image segmentation and improve segmentation consistency. 
2. Image acquisition and quality
Image quality in medical imaging can be influenced by many factors, including patient 
preparation, hardware/vendors and software, and protocols used for image acquisition. 
Radiomic studies that have been published so far have mainly been retrospective, meaning 
that they are based on the analysis of images that have been acquired as part of routine 
clinical practice. Though this can yield a much larger amount of data compared to prospective 
studies, the data is less homogeneous because imaging protocols will have typically not 
been standardized for the purpose of the study. The resulting heterogeneity in imaging can 
substantially affect the extracted radiomic feature values and the extent to which the images 
will be usable for automated analysis8,9. Even in case of (prospectively acquired) homogenized 
acquisition, day-to-day noise and artefacts can still severely impact the image quality, and 
subsequently the quality of extracted features10.
3. Feature extraction
The next step in the workflow is to extract the radiomic features. Generally, several 
preprocessing steps are applied first, including resampling of the pixel spacing and 
normalization of the gray value intensities to reduce acquisition-related variations. Then, a 
large panel of features is extracted describing the histogram, shape and texture of the ROI11. 
Additional image filtration can be applied to emphasize certain aspects of the image5,12. 
Though many of the mathematical algorithms used to extract radiomics features are well 
known and documented, there is a lack of standardized implementations. In other words, no 
standardized tools or software packages exists to apply these algorithms including the necessary 
pre-processing steps to extract features from the imaging data. As a result, many studies that 
report on radiomics analysis use in-house developed software that lack transparency, which 
severely hampers the reproducibility and comparability of the reported results.
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4. Feature selection, classification and modeling 
The final step in the workflow is the analysis of the extracted features and the development 
of a model to correlate them to the outcome under investigation. In radiomics studies, this is 
done using a data-driven analysis, where the correlation of a large panel of tests (the radiomic 
features) to the desired outcome is inferred through a multistep process of selecting and 
classifying valid predictors.13 An important pitfall of radiomics studies is that the number of 
available features (in the order of hundreds to thousands of features) tends to be much larger 
than the number of subjects in the dataset. This causes radiomics to suffer from “the curse of 
dimensionality”, where the amount of features or dimensions is so large that combining them 
into a single model becomes very difficult14. To tackle this problem and prevent overfitting 
of the model, a smaller subset of features must therefore first be selected. This can either 
be done using “supervised” methods, where features that show good individual performance 
in univariate analysis are more or less cherry-picked, or “unsupervised”, where a subset is 
selected based merely on the distribution of features in relation to each other. In addition, 
features can be selected on their “stability”, meaning that features that are significantly 
affected by acquisition or segmentation induced variability (the “unstable features”) are 
excluded. After selection of a final subset of candidate features a predictive model can be 
trained. To do so, a dataset is generally divided into several subsets, ideally including a training 
set to fit the model, a validation or “tuning” set to optimize the model settings controlling the 
training process, and a final test set to evaluate the performance of the developed model. 
Preferably, this test set should be an independent cohort of cases not used for model 
development16, though in many of the small scale and preliminary reports published so far, 
such an independent test dataset is lacking.
Radiomics in rectal cancer
In this thesis, the concept and stepwise implementation of Radiomics and AI in oncology 
will be assessed using rectal cancer as a clinical case example. Colorectal cancer ranks 3rd 
for incidence and 2nd for cancer deaths worldwide, of which over 30% concern cancers of 
the rectum17. Traditionally, the standard treatment of rectal cancer has been radical surgery, 
preceded by neoadjuvant radiotherapy or chemoradiotherapy (CRT) in case of more locally 
advanced rectal cancers (LARC) to achieve downstaging and enhance the chance of a curative 
resection18. More recently, the concept of “organ-preservation” was introduced to the 
treatment landscape for rectal cancer. Small (early) tumors may be managed with less-invasive, 
local excision surgery and advanced tumors that show a very good response to neoadjuvant 
treatment may be managed with minimally invasive or even non-operative treatment 
strategies19,20. The latter, commonly referred to as “watch-and-wait” means that patients with a 
clinical complete response after neoadjuvant treatment are deferred from surgery and instead 
regularly monitored with clinical examination and imaging. With this strategy the rectum may be 
spared in up to 20%21 of patients undergoing neoadjuvant treatment with very promising results 
in terms of long term oncological outcome and survival22,23. These developments in treatment 
have generated a new array of clinical questions where imaging may play an important role: 
how can we best select the patients that may benefit from these organ-preserving treatments? 
In other words, how can we best differentiate the high-risk from low-risk tumors and can we 
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predict how patients will respond to neoadjuvant treatment, so that the treatment plan may 
be optimized accordingly? Several studies have investigated the role of quantitative imaging 
analysis to predict response to chemoradiotherapy in rectal cancer. Parameters derived from 
dynamic contrast enhanced MRI24,25 and diffusion weighted imaging25–28 have shown promise as 
potential imaging biomarkers of response, albeit with varying results29. Only a limited number 
of studies have investigated the potential of radiomics in rectal cancer, so far mainly focusing 
on the assessment of response after completion of neoadjuvant therapy30–32. In addition to 
these previous works, this thesis will focus on investigating the potential of radiomics to predict 
response to neoadjuvant therapy upfront, using MRI data acquired prior to the start 
of treatment. 
Aim of this Thesis
The overall goal of this thesis is to address the key steps and challenges in the radiomics 
workflow described above, aiming to bring radiomics closer to implementation in clinical 
practice. We will do so by using the clinical case example of rectal cancer imaging that can 
serve as a blueprint for future studies investigating applications of radiomics and AI in other 
(oncologic) imaging fields. 
Outline of this Thesis
Chapters 2 and 3 address the challenge of image segmentation. Chapter 2 focuses on the 
development, training and testing of a deep learning network for fully automatic segmentation 
of rectal tumors on MRI. In Chapter 3 this algorithm is further optimized and validated in a large 
multicenter dataset. Additionally, this chapter investigates the influence of scan quality and 
tumor complexity on automatic segmentation performance. 
Chapter 4 focuses on scan-quality – an important prerequisite for radiomics and AI analysis 
– and evaluates how the quality of diffusion-weighted MR imaging of the rectum may be 
improved by applying a preparatory micro-enema shortly prior to acquisition to reduce the 
presence of gas-induced susceptibility artefacts.
In Chapter 5 we developed an open-source python software package for easy, transparent and 
reproducible radiomics feature extraction.
Finally, Chapter 6 puts the radiomics model to the test in a clinical paper investigating 
the potential of radiomics for the pre-therapy prediction of response to neoadjuvant 
chemotherapy in rectal cancer, based on primary staging MRI data.
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Abstract
Multiparametric Magnetic Resonance Imaging (MRI) can provide detailed information of the 
physical characteristics of rectum tumors. Several investigations suggest that volumetric 
analyses on anatomical and functional MRI contain clinically valuable information. 
However, manual delineation of tumors is a time consuming procedure, as it requires a high 
level of expertise. Here, we evaluate deep learning methods for automatic localization and 
segmentation of rectal cancers on multiparametric MR imaging. MRI scans (1.5T, T2-weighted 
and DWI) of 140 patients with locally advanced rectal cancer were included in our analysis, 
equally divided between discovery and validation datasets. Two expert radiologists segmented 
each tumor. A convolutional neural network (CNN) was trained on the multiparametric MRIs of 
the discovery set to classify each voxel into tumor or non-tumor. On the independent validation 
dataset, the CNN showed high segmentation accuracy for reader1 (Dice Similarity Coefficient 
(DSC=0.68) and reader2 (DSC=0.70). The area under the curve (AUC) of the resulting probability 
maps was very high for both readers, AUC=0.99 (SD=0.05). Our results demonstrate that deep 
learning can perform accurate localization and segmentation of rectal cancer in MR imaging in 
the majority of patients. Deep learning technologies have the potential to improve the speed 
and accuracy of MRI-based rectum segmentations.
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Introduction
Magnetic Resonance Imaging (MRI) is an integral part of the diagnostic work-up of rectal cancer 
and plays an important role in treatment planning. In addition, MRI can play a role in predicting 
clinically relevant endpoints, one of the most important ones being the response to neoadjuvant 
treatment1–3. Predicting which patients will show a very good response to treatment can have 
important clinical implications, since these patients may be considered for organ-preserving 
treatment strategies (local excision or watchful waiting) as an alternative to standard surgical 
resection4. In carefully selected patients these organ preserving treatments can considerably 
improve quality of life with a good oncological outcome. 
  
A promising technique to assess response to neoadjuvant treatment is diffusion-weighted MRI 
(DWI). Various studies have shown that – as an addition to standard morphological MRI – DWI 
can aid in assessing response to chemoradiotherapy, in particular to differentiate residual 
tumor within areas of post-radiation fibrosis after CRT. For this purpose use of DWI is now even 
recommended in international clinical practice guidelines for rectal cancer imaging4.
Particularly good results have been shown for volumetric measurements derived from diffusion-
weighted imaging (DWI)5–8. Furthermore, ADC and histogram features derived from DWI-MRI 
have shown promise as quantitative imaging biomarkers for therapeutic outcome4,5,9,10. 
Most of these measures are calculated from regions of interest (ROI) of the tumor that are 
typically obtained after manual tumor segmentation by experienced readers. Studies have 
indicated that whole-volume tumor segmentations, as opposed to single slice or sample 
measurements, provide the most reproducible and accurate estimates of the true tumor 
volumes11,12. The main problem with manual segmentation approaches is that these are highly 
time consuming, up to 18 minutes per tumor13, and as such unlikely to be implemented into daily 
clinical practice. Previous studies have explored ways to automatically perform segmentations 
using software algorithms6,13. These approaches work best on diffusion-weighted images, 
as these highlight tumor and suppress background tissues, thereby providing a high 
tumor-to-background ratio. 
Unfortunately, high signal on DWI is not limited to tumor tissue only. Other anatomical 
structures in the pelvis (e.g. perirectal lymph nodes, prostate and ovaries) as well as artefacts 
may also show similar hyper-intensity and may not be recognized as such by typical simple 
segmentation algorithms causing these algorithms to fail to produce sufficiently accurate 
results13. In such cases, the manual input required from an experienced reader will not be 
limited to a threshold value or a seed point (in case of region growing), but will include manual 
corrections to adjust the segmentations for these effects13. Thus, there is an obvious need 
for smarter algorithms that can automatically localize and perform accurate segmentations of 
rectal tumors, which can reduce the need of expert input (Figure 1). 
Such fully automatic alternatives would also facilitate the generation of segmentations for large 
cohort studies, which is beneficial especially in light of new research developments such as 
Radiomics14,15, where complex tumor phenotypical characteristics are quantified and correlated 















































































































































































































































































































































































































































delineation of the region of interest to be described. Artificial intelligence (AI) aims to mimic 
cognitive, labor intensive tasks via complex computational models trained on top of existing 
datasets. A computational model trained using the input from expert readers (radiologists) to 
automatically localize and segment rectal cancer in MR images, could represent a potential 
solution to this problem. 
Novel AI technologies, such as deep learning models, have been exploited in recent years with 
impressive results. Convolutional neural networks (CNNs) based deep learning approaches 
can learn feature representations automatically from the training data. The multiple layers of 
the CNNs aim to process the imaging data with different levels of abstractions, enabling the 
machine to navigate and explore large datasets and discover complex structures and patterns 
that can be used for prediction16. The advancement of these techniques has been made 
possible by the availability of large imaging data and the accessibility of dedicated hardware 
devices such as graphical processing units (GPU)15,16. Particularly in the field of biomedical 
imaging, deep learning has been largely exploited for detection and segmentation purposes, 
where these methods are proven to systematically outperform traditional machine learning 
techniques17–19. 
In this study, deep learning methods (CNNs) have been used to fully automatically localize and 
segment rectum tumors. To evaluate the performance of deep learning based segmentations, 
we compared them to manual segmentations of two independent expert radiologists. 
Deep learning technologies have the potential to improve the speed and accuracy of MRI-
based rectum segmentations in clinical settings. 
Background work
To the best of our knowledge, few investigations were conducted on the automatic localization 
and segmentation of rectal cancer. Irving et al.20 proposed an automatic segmentation 
procedure, based on DCE-MRI, where the authors accounted for the multidimensional nature 
of DCE signal through a modified version of the supervoxel algorithm corrected by a graphical 
model producing successful results. Although DCE-MRI tends to give a much clearer and less 
noisy signal compared to DWI, our method achieved comparable results to the one presented 
in this study. The most popular semi-automatic approach is region growing. Day et al.21 used 
region growing on FDG-PET on phantoms, leading to better results than thresholding of 
the standardized uptake value (SUV). In this case the intent of the authors was to optimize 
treatment planning. Region growing was also used by van Heeswijk et al.13, who concluded that 
it could represent a more convenient replacement for manual delineation in terms of time. 
Although the results showed a decrease in the amount of time required, manual input was still 
required and a DSC > 0.7 could only be achieved when the result of the region growing was 
adjusted by an experienced radiologist. 
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Table 1. Patient Characteristics
(α) according to the segmentation performed by the experienced reader. 
No significant difference has been found between the two centers.
Materials and methods
Subjects and Study Dataset
For this study we retrospectively selected 140 patients (97 males, median age 67, range 
43 - 87) with biopsy proven locally advanced rectal carcinoma (LARC) from a previously 
reported bi-institutional study cohort5. No significant difference in clinical parameters was 
observed between the two centers (see Table 1). All patients in this cohort have undergone 
multiparametric (mp) MRI, consisting of T2 weighted and diffusion weighted imaging (DWI), prior 
to standard chemo-radiotherapy treatment (CRT), using either an Intera (Achieva) or Ingenia 
scanner (Philips Healthcare, Best, The Netherlands) (center A, 91 patients) or a Magnetom 
Avanto system (Siemens Healthcare, Forchheim, Germany) (center B, 49 patients) with a phased 
array surface coil. Both T2w and DWI sequences were axially angled perpendicular to the tumor 
axis defined on a sagittal scan. The diffusion sequence was performed using b-values b0, 
b500, and b1000 (center A) or b1100 (center B). Patients did not receive bowel preparation. 
As described previously, all research was performed according to guidelines and regulations of 
The Netherlands5. In short, according to the Dutch law, retrospective studies are not subject 
to the Medical Research Involving Human Subjects Act and informed consent is not required22. 
Detailed parameters of the sequences are specified in Table 2. 
Whole-volume tumor segmentations were available for all patients and were done by an 
experienced reader (Reader 1, DMJL) on the highest b-value (b1000 or b1100) DWI, according to 
methods previously reported13, where the reader created an initial segmentation using a 
simple region growing algorithm and manually adjusted to fit the borders of the tumor. 
These segmentations were used as ground truth. Additionally, segmentations performed on 
the same dataset and in the same manner by an independent reader (Reader 2, MJL) were 
retrieved. These segmentations were used as additional check. 
Chapter 2
24
Table 2. Sequence parameters of the diffusion-weighted 
imaging used during the study period.
Fatsat: Fat Saturation, SPIR: Spectral Attenuated Inversion Recovery, 
SPAIR: Spectral Pre-saturation with Inversion Recovery, STIR: Short T1 Inversion Recovery.
Imaging data of 140 patients were included in our analysis. Patients were assigned to discovery 
or validation dataset depending on their identifier: even numbers were assigned to discovery 
dataset (N=70), odd numbers to validation dataset (n=70). For the discovery dataset, 
there were no errors within the imaging data and segmentations, and therefore 70 cases 
were used for training. For the validation dataset, three cases had to be excluded due to 
misalignment between DWI and T2 caused by an error in the DICOM metatags, one case where 
the DWI suffered from severe ghosting artefacts, and one case in which the segmentation file 




All images underwent standardization of the intensities, namely the intensity distribution was 
set to have mean zero and standard deviation one. Deformable registration was applied using 
the elastix toolbox23,24 to compensate for the anatomical displacement of organs and tissues 
in different imaging sequences during the acquisition procedure. The DWI-b0 was used as 
reference image, since it visualizes anatomical structures like the T2w and, at the same time, 
is well aligned to the DWI-b1000. The deformation field was estimated via adaptive stochastic 
gradient descent25 minimizing the advanced mattes mutual information26. Transform bending 
energy27 was used as penalty measure to correct for anatomically unrealistic transformations. 
To properly simulate the small, local movements in the bowels, a dense sampling grid of 4 mm 
together with a strong weight on the penalty measure (1 : 20) was applied. 
Deep Learning (CNN) architecture. 
In this study, a CNN architecture was implemented to function as voxel classifier. More 
specifically, for each voxel v we (1) extracted a fixed-size patch surrounding v, (2) classified the 
patch via a trained instance of the CNN, (3) collected the resulting probability, and (4) assigned 
the resulting probability to v. By repeating the procedure for each voxel of each image, 
we could generate a probability map, where p(v) is the probability of voxel v to represent tumor 
tissue. The segmentation was generated by thresholding of the probability maps (voxels with p(v) 
≥ 0.5 were classified as “tumor”, and as “not tumor” otherwise) and subsequent selection of the 
largest connected component. Figure 2 offers a schematic synthesis of the whole process. 
Patch extraction
N voxels were randomly sampled from each of the foreground (i.e. tumor region) and 
background (i.e. non tumor region) regions. This ensured a balanced representation of the two 
classes during the training procedure. For each voxel, we extracted the surrounding in-plane 
patch of size M×M in all MR sequences. Each sequence was then fitted in one of the three 
channels of a standard RGB picture. The ground truth associated with each patch was the label 
of the central voxel. 
Some regions are easier to classify, such as hypointensity on the DWI. Other regions instead 
are more challenging: for example, the prostate and the tumor regions have similar intensity 
and heterogeneity on T2w and DWI. Intuitively, the classifier should be able to spend more 
time learning to how to correctly classify these difficult regions of the image, and less time 
on regions that are easily classifiable. To translate this concept in implementation, the 
background class was divided in three regions: I) the area surrounding the tumor (RB1) defined 
by morphological dilation of the tumor segmentation with a spherical structural element of 1 cm 
radius; II) the regions hyper-intense on the DWI (RB2) defined by thresholding on the DWI at µ + 
2σ. Since all images have been standardized, this operation will result on the thresholding at a 
value of 2.00; and III) the remaining areas (RB3) defined by the voxels not belonging to either R
B
1 




3, and N/2 voxels from R
B
2, summing up to total 
N non-tumor voxels from the background class. Figure 2a shows a schematic representation of 




Figure 2. Scheme of the Proposed Solution. (a) On the left-hand side, a multiparametric representation of 
the imaging is created via fusion of corresponding slices from different sequences into the color channels of the RGB model. 
In the center, the label map is first divided in tumor region (RT) and the background regions (RB) according to the delineation 
done by the experienced reader. On the right-hand side, N voxels (together with their surrounding patch) are then randomly 
sampled from these regions to maintain a balance between number of voxels representing the tumor and number of 
voxels representing healthy tissue. (b) The architecture of the network, which is trained with the patches of the images in 
the discovery set. The patches of the images in the test set are used to control for model overfitting. (c) The 3D probability 
map is generated by classification of each voxel using the trained model. The probability map is thresholded to find the 
components where the probability of tumor is higher than the probability of healthy tissue. The largest component is selected 
as segmentation of the tumor.
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Network Definition
The network used for the classification of each patch is composed of a total of nine layers: 
two subsequent convolutional layers followed by a max pooling layer; a couple of smaller, 
subsequent convolutional layers, each followed by a max pooling layer; two fully connected 
layers at the end culminating in the output layer. This architecture is similar to the one 
proposed in28, with the addition of a convolutional and max pooling layer. Dropout29 of
1/2 was used after each fully connected layer and 1/3 after each max pooling layer30. 
Leaky rectified linear unit (ReLu)31 was used as a nonlinearity in each layer, except on the 
output layer, where a softmax was used instead. Small filters of 5×5 or 3×3 are used at each 
convolutional layer; along with stride one and full padding. Stride two was used in the max 
pooling. Twenty-four features were used in the first convolutional layer, number which doubles 
in each subsequent layer (i.e. 24, 48, 96, 192), amounting for a total of 360 filters throughout 
the entire network. Figure 2b shows a schematic representation the network structure. 
Cross entropy was used as cost function, together with a small L2 regularization on the network 
parameters. Adadelta32 with learning rate η = 0.001 and decay ρ = 0.9. 
The discovery set was divided into training set (80%) and test set (20%). The training set was 
used for training the net, the test set was used alongside the training procedure to check for 
model overfitting. The training procedure was programmed to stop when no improvement 
on the cost δ of the test set was made for at least five consecutive epochs, where the 
improvement was defined as  δEPOCH-1 - δEPOCH > 10 – 3. The implementation of the algorithm was 
based on popular Python libraries: Lasagne and Theano33.
Statistical Analysis
Segmentations were generated by feeding the patch of each voxel of mpMR to the algorithm 
and assigning the resulting probability to that voxel. The segmentation was generated by 
thresholding of the probability map at p = 0.5. Additional selection of the largest component 
allowed the exclusion of small isolated voxels, which might pass unseen by most human readers. 
Figure 2c shows an example of this process. 
In stochastic processes where samples are randomly selected, the result might often be not 
representative, with a significant variance in the final classification results. To evaluate the 
stability of the algorithm, we repeated the entire sampling, training and testing procedure four 




Deep Learning (CNN) Training
To develop a deep learning based algorithm for the fully automatic localization and 
segmentation of rectum tumors, we used independent discovery and validation datasets 
to develop a CNN-based network and validate its performance. The CNN was trained on 
multiparametric MR imaging (1.5T, T2-weighted and DWI) of 70 patients, using the segmentations 
performed by expert reader 1. For each patient, 5000 patches (size M×M = 21×21 voxels) were 
created by combining T2-weighted, and DWI images, for both tumor and non-tumor areas 
(Figure 2a). The discovery data consisted of an independent discovery set (totalling 560K 
patches) and test set (140K patches). The algorithm reached a loss on the discovery set of 0.275 
and 0.331 on the test set. The accuracy was 0.895 and 0.871, respectively. Figures 3a, 3b and 3c 
show the improvement of accuracy, the minimization of the cost function and its improvement 
over time. Notice from the graph presented in Figure 3c that no major improvement on the 
cost function has been recorded after the 50th epoch.
Validation of CNN classifier
The performance of the CNN classifier was validated on the validation dataset consisting of 
multiparametric MR imaging of 65 patients. For each patient volumetric tumor segmentations 
were generated and compared to both expert readers (Figure 1b). Three cases had to be 
excluded where there was no agreement between expert readers. Therefore, data of 62 
patients were used to validate the performance of the classifier. For all cases, the CNN could 
successfully generate volumetric tumor segmentations. To evaluate the performance of the 
CNN on a voxel-by-voxel basis, the area under the curve (AUC) was computed between the 
CNN probability maps and the segmentations of the experienced readers. The AUC of the 
resulting probability maps was very high for both readers, AUC = 0.99 (0.05 SD), with no 
significant difference between readers. Figure 3d shows AUC distributions for both readers.
 
From the probability maps we then generated volumetric segmentations. To evaluate the 
performance of the segmentation the Dice Similarity Coefficient (DSC) was used. The DSC is a 
statistical measure of spatial overlap frequently used to compare segmentations. The average 
DSC between the two expert readers was high (0.83, SD=0.13). The DSC between the algorithm 
and Reader 1 was 0.68 (0.07 SD) and Reader 2 was 0.70 (0.07 SD), with no significant difference 
detected between the two distributions (p = 0.31, t-test). Figure 3e shows DSC distributions 
between the algorithm and each reader, and between the two readers. Figure 1b shows an 
example of a tumor successfully delineated by the algorithm (0.99 AUC, 0.85 DCS). Notice that 
the CNN was trained on segmentations of expert reader 1 in the discovery dataset. 
However, on the validation dataset the performance of the CNN was similar with both readers 




































































































































































































































































































































































































































































The algorithm resulted in a relatively poor result (DSC < 0.50) in ten cases. Figure 4 shows 
an example of a tumor correctly classified by the algorithm but resulting in a poor DSC after 
thresholding and selection of the biggest connected component (0.98 AUC, 0 DSC), as the 
tumor was not the biggest component. In this case, the testicles (visualized in the lower part of 
the image) were assigned a probability greater than 0.5, enabling them to survive the threshold 
procedure and be selected as candidate segmentation. 
Stability of the Sampling Process. 
To access the stability of the sampling procedure and reproducibility of the model across 
different sampled voxels, the entire discovery and validation procedure was repeated additional 
four times. The final validation accuracy resulting from each individual training procedure 
(between 0.875 and 0.895), as well as the cross entropy (between 0.268 and 0.30), was stable. 
Each trained algorithm was used to generate the segmentations, resulting in four segmentations 
for each case. The Intraclass Correlation Coefficient (ICC) was used to access the agreement 
across different nets in terms of DSC. The overall agreement was very high (ICC = 0.83, 95% CI 
0.77 – 0.88, p < 0.001). 
Figure 4. Example cases. Six example cases of the segmentation performed by the CNN. The algorithm correctly 
localized and segmented the tumor in case I to IV (small FOV images), but failed in cases with larger FOVs (cases V and VI) 




Our aim was to develop a deep learning based network for the fully automatic localization and 
segmentation of locally advanced rectal tumors. Overall results show good performance of the 
algorithm, with segmentations comparable to those performed manually by an expert reader 
with a DSC of 0.70. In terms of classification, the high AUC of 0.99 suggests the ability of the 
algorithm to properly classify tumor voxels and therefore locate cancer tissue in the image. 
At visual inspection of the probability maps, one can appreciate how non-malignant 
hyperintensity of the DWI are attenuated with lower probabilities, whereas the tumor retains 
higher values. 
After thresholding and selection of the largest component as candidate segmentation, the 
algorithm achieved an overall DSC of 0.70. At first glance, this is lower than the DSC reached 
between both readers on this dataset. In this case however the reader could rely on a semi-
automatic procedure (region growing) known to increase the DSC13. Fully manual segmentation 
is reported to provide a lower DSC of 0.6813, leaving open the question of whether the region 
growing algorithm could really provide a much more precise delineation or if the experienced 
readers were partially influenced by the result of the algorithm. Interesting enough, DSC 
variability was lower than the variability between experienced readers (0.07 vs 0.13 SD). 
During the training of the CNN classifier, the algorithm showed decreased performance in 10 
cases of the validation dataset. In each of these cases the AUC was > 0.90 but the DSC was 
zero, suggesting the algorithm managed to identify the tumor tissue in the image but failed to 
select the correct candidate. Seven cases out of ten were images acquired at the center B, 
which applied an imaging protocol with a larger field of view (FOV). The larger FOV inevitably 
included in the images large chunks of subcutaneous adipose tissue, or anatomical parts 
– e.g. the testicles –, which were not present in the discovery set (Figure 4). Although the 
tumor region resulted in higher probability voxels, after thresholding these adipose tissue or 
anatomical parts were larger than the tumor and therefore selected as candidate. 
Including more examples from center B will likely enable the network to learn to recognize 
and remove artefacts in these peripheral areas. Figure 4 shows two example cases of a male 
patients from center B, where the testicles were misclassified as tumor. 
The remaining three cases from center A showed large fat suppression artefacts, rarely 
present in the rest of the dataset. Most likely, the scarcity of these examples is the reason of 
misclassification. This indeed represents the main drawback of supervised learning procedures 
in general, which are often unable to properly classify underrepresented cases. The same 
effect can be observed on a microscale in Figure 1, where the segmentation generated by 
the algorithm includes non-tumoral hyperintensities, most likely fecal matter. Given that all 
patients underwent preparatory enema before image acquisition, fecal matter is rarely present 
and only in small quantities. Its under representation in the training set, and the vicinity to the 
tumor leads the algorithm to assign a tumor probability > 0.5 – yet smaller than the probability 
assigned to the tumor. 
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Deep learning has been largely used before for segmentation tasks in medical imaging. 
Out of all possible architectures, we chose this for its straightforwardness and, most 
importantly, the limited number of images required for training the algorithm. The strategy of 
using multiple patches from the same patient allows us to generate a large imaging tensors upon 
which the algorithm can be trained. The patch size chosen allows focusing on a small region 
without including too much surrounding, but can still generalize textural patterns of specific 
tissues and organs. Larger patches in fact (e.g. M = 35) as well as smaller patches 
(e.g. M = 11) resulted in higher training error. These small patches, however, might not provide 
enough anatomical information needed in some other applications. In Figure 4, for example, 
we can see how the algorithm selected a group of voxels outside the pelvis. Fully convoluted 
end-to-end procedures, such as the one presented in SegNet34 or U-Net35,36 where 2D slices 
of MR volumes or entire 3D volumes are fed to a network able to directly generate the target 
segmentation, would represent an alternative approach worth investigating. Such approach 
would recognize unlikely tumor locations outside or on the border of the pelvic area, and 
exclude them automatically. The patch based approach adopted in this study aims to provide 
the network with an artificially balanced, multiparametric training set from a relatively small 
dataset via a weighted sampling procedure favoring more challenging regions such as tumor 
borders and diffusion hyperintensities often found in nearby prostate and seminal vesicles. 
Neuroradiology remains the main area of focus of research on segmentation algorithms, 
and several algorithms and architectures have been proposed for brain tumor segmentation, 
especially in the context of multiparametric imaging37–39. Imaging of the lower abdomen however 
poses a challenge to automatization, partially because of the bowel movements, which makes 
it challenging to use voxel-wise mpMRI, and partially because of the high number of artefacts. 
Although bowel movements can be partially attenuated by deformable registration protocols, 
such as the one designed in this study, the result is yet suboptimal and needs to be investigated 
further. Common artefacts are learned as false positive by the algorithm, recognized and 
removed from the result. Rare artefacts and presence of anatomical parts not seen in the 
discovery set are still misclassified.
This algorithm represents a preliminary result to support the utilization of deep learning in 
colorectal MR. We intend to further optimize the protocol, mainly by (1) focusing on alternative 





Our results demonstrate that deep learning can perform accurate localization and segmentation 
of rectal cancer in MR imaging in the majority of patients. Deep learning technologies have the 
potential to improve the speed and accuracy of MRI-based rectum segmentations, as manual 
delineation has been shown to be reader dependent and often time consuming, which limits its 
utility in practice and represents one of the major obstacles in the design of large quantitative 
imaging studies. Automatic segmentation procedures, such as the one presented in this study, 
aim to overcome this obstacle by offering a viable alternative to manual delineation. 
Further validation of these technologies is warranted before clinical application. If these 
methods prove reliable, its impact in clinical management of rectal cancer could be significant 
by providing an efficient and accurate tool to assess residual tumor burden after preoperative 
treatment with subsequent better stratification of patients for organ preservation resulting in a 
higher quality of life.
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Abstract
Purpose
To develop and test the performance of a fully automated deep learning segmentation 
algorithm in a large and heterogeneous clinical multi-center dataset of multiparametric rectal 
MRIs, taking into account inter-reader variability.
Materials and Methods
This retrospective study was approved by our local institutional review board. All data was 
collected and stored in compliance with HIPPA guidelines. Baseline staging MRIs including 
T2W, DWI and ADC maps of 603 patients from 6 institutions were analyzed, randomly split 
into train, tune, and test cohorts (ratio of 5:1:4). An expert-radiologist manually delineated 
all rectal tumors to serve as training input and ground truth for analysis of network inferred 
segmentations using the dice similarity coefficient (DSC). A second expert-radiologist 
independently re-segmented 142 patients in the test cohort to calculate inter-reader 
agreement which served as the target level of performance. To evaluate effects of image quality 
and “case mix” on the network performance, DWI scan quality (SNR and artefacts) and overall 
morphological tumor complexity (signal heterogeneity, border irregularity) were assessed using 
3-5 point Likert-scores. An attention-gated U-Net was trained, with hypertuning via gridsearch. 
Performance of the network was compared to expert inter-reader agreement using Wilcoxon 
signed-rank tests. 
Results
A deep learning network based on the full dataset of T2W-MRI, DWI and ADC showed good 
performance with a DSC of 0.669 in the test set, compared to an expert inter-reader 
agreement of DSC 0.749. Results based on T2W-data only were significantly poorer (DSC 
0.314, p<0.001). More complex tumors resulted in significantly lower network performance and 
inter-reader agreement. Low DWI image quality (low SNR) negatively affected the networks’ 
performance, but not inter-reader agreement. In the subgroup of good quality (high SNR) DWI 
scans, network performance was comparable to inter-reader agreement (DSC 0.708 vs 0.741). 
Conclusion
Deep learning can be used for fully-automatic segmentation of rectal tumor segmentation on 
MRI scans, despite large heterogeneity in clinical data and could thus become an important 




Recent breakthroughs in AI allow for the automation of complex image analysis tasks that 
up to a few years ago could only be done by humans1. These breakthroughs could result 
in improved prediction of staging, therapeutic response and prognosis through uses of 
automated extraction of quantitative features from medial image data. To extract quantitative 
features, ranging from volume to complex radiomics features, typically requires segmentation 
of a certain region or VOI within the image, such as the primary tumor under investigation. 
Segmentation methods vary from simply placing a standardized shape (e.g. a circle) around the 
tumor, to whole-volume segmentation, where the tumor is delineated in detail on a slice-by-
slice basis generating a 3D VOI. The latter is generally considered to provide the most accurate 
approximation of the true tumor volume and has also been shown to yield the most stable and 
performant quantitative imaging features2–4. The main drawback of whole-volume VOIs is that 
these are generally obtained manually and preferably by experienced readers, which is a highly 
labor intensive and time-consuming job5. For this reason, segmentation remains one of the 
major bottlenecks that hamper implementation of quantitative medical image analysis in time-
constrained day-to-day clinical workflows.
Several studies aimed to address this issue by replacing manual segmentation by semi-
automated algorithms, i.e. algorithms that still require some manual user input5–7. More recent 
studies have mainly focused on fully-automated segmentation algorithms based on deep 
learning networks. An example of such a network is the “U-net”, a deep learning architecture 
that produces segmentation maps with the same size as the input image in a single forward 
pass. In a recent study by Schlemper et al.8, this architecture was expanded with attention 
gates, helping the network to focus on the area of interest at minimal increased computational 
overhead. In rectal cancer, published reports using deep learning networks have shown 
encouraging results9–14. However, these reports have so far mainly been based on single 
center study cohorts, with highly curated datasets. While this will yield the best performance 
in the developed model, it is less representative of the general clinical setting, where such 
homogeneous, good quality data is often not available, especially when dealing with multi-
sequence MRI data where acquisition protocols and image quality are less standardized and 
more prone to variations between centers compared to for example CT and PET data. 
For segmentation tools to be generally applicable, they must therefore also be robust to 
variations in the data, like different vendor systems, MR protocols and large variance in scan 
quality and tumor complexity. 
Another limitation is that published algorithms are generally trained with manual segmentations 
generated by a single reader that are at the same time used as the ground truth to test the 
network’s performance. This introduces bias and does not take into account effects of inter-
reader variations that may occur (even between highly expert readers5,7), which may affect the 
validity of these segmentations when used as a standard of reference. 
The aim of this study is to investigate the accuracy of a fully automated deep learning 
segmentation algorithm in a real-world clinical dataset of rectal MRIs from six institutions, 





This retrospective study was approved by our local institutional review board. All data was 
collected and stored in compliance with HIPPA guidelines. For this study cases were selected 
from a study dataset collected as part of a larger ongoing multicenter retrospective research 
project on neoadjuvant treatment prediction in rectal cancer, including patients who 
underwent rectal MRI including T2W and DWI at baseline, i.e. prior to treatment. 
Imaging examinations were performed between January 2012 and January 2017 in 6 institutions; 
4 regional non-university centers Noordwest Ziekenhuisgroep (Alkmaar, center 1), Deventer 
Ziekenhuis (Deventer, center 2), Zuyderland Medical Center (Heerlen, center 3), Jeroen Bosch 
Ziekenhuis (Den Bosch, center 4), one university hospital Maastricht University Medical Center 
(Maastricht, center 5) and one third-line referral center The Netherlands Cancer Institute 
(Amsterdam, center 6). Inclusion criteria for the current study consisted of: [1] biopsy proven 
adenocarcinoma of the rectum and [2] availability of a baseline MRI including at least a T2W and 
DWI sequence. Reasons for exclusion (see Figure 1) were mucinous type adenocarcinoma (as 
these exhibit distinctly different characteristics on both T2W and DWI15,16), more than 1 tumor 
lesion within the field of view (i.e. simultaneous tumor in rectum and sigmoid colon), non-
diagnostic image quality (e.g. severe artefacts in case of hip prosthesis), and tumors that were 
not completely included in the field of view of either the T2W and/or DWI sequence. 
Study cases were randomly assigned to train, tune and test sets using a ratio of 5:1:4.












Mucinous tumor type: n=30
Severe geometric mismatch: n=3
DWI non-diagnostic: n=28



































































































































































































































Images were all retrospectively collected and had previously been acquired according 
to routine practice in the 6 different centers using a variety of MR-system vendors and 
acquisitions protocols that are summarized in Table 1. For the current study, the transverse 
DWI and T2W sequences (angled in similar planes) were selected. From each DWI sequence, 
a high b-value image (b600-1000) was selected for analysis. ADC maps were recalculated for 
the purpose of this study using a mono-exponential regression model including all available 
b-values. Voxels with ADC values < 0 and > mean + 6 standard deviations were marked as 
‘invalid’ values and set to 0. In total, 3 imaging datasets (T2W, high b-value DWI, ADC) were thus 
selected for further analysis. Geometric alignment between sequences (T2W and DWI/ADC) was 
assessed visually; scans exhibiting severe misalignment were excluded (see Figure 1).
Manual image segmentation and quality assessment 
Rectal tumors were segmented using 3D-slicer (version 4.11)17 using the high b-value DWI 
combined with the T2W sequences for visual anatomical correlation. Tumors were coarsely 
segmented using the “Level tracing” algorithm, followed by full manual revision and adaptation 
by an expert reader (R1, DMJL, board certified radiologist with > 10 years’ experience in 
assessment of rectal cancer on MRI) who traced the tumor boundaries thereby adapting and 
finalizing the segmentations on a slice-by-slice level. A randomly selected subset of 142 cases 
from the test set was independently processed using the same methods by a second expert-
reader (R2, MJL, board certified radiologist with similar experience level as R1) to analyze inter-
reader agreement. 
In addition, R1 visually assessed the quality of each DWI scan in the dataset by scoring the 
overall DWI image quality (SNR and image resolution) and the presence of artefacts (signal pile 
up and/or geometrical distortions caused by susceptibility effects) at the level of the tumor, 
using 5-point Likert scales, ranging from 0 (= non-diagnostic / severe artefacts) to 
4 (= excellent quality/no artefacts), similar to scoring systems previously reported18. 
Quality assessment was primarily focused on DWI as these sequences are known to be 
most prone to quality variations and will therefore likely have the most effect on network 
performance19. Finally, the overall level of tumor complexity was scored for each case to 
estimate if a tumor would be easy or difficult to segment. The latter was assessed using a 
3-point scale based on tumor morphology: 0 = difficult to segment (heterogeneous, irregularly 
shaped and/or poorly demarcated tumor), 1 = moderately difficult to segment (partly 
heterogeneous and/or irregular) and 2 = easy to segment (homogeneous, regular and well 
demarcated). Representative examples of the different Likert scores used to assess DWI quality 
and tumor complexity are shown in Figure 2.
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Image pre-processing and data augmentation
Image pre-processing and data augmentation was achieved using the “numpy” (1.17.4) and 
“SimpleITK” (1.2.3) packages in Python 3.6.8.
For each included case, the 3 input images (T2W, high b-value DWI and ADC-map) were 
resampled using a B-Spline interpolator and combined into 1 single 3-channel multi-sequence 
image with (x, y, z) spacing of 1x1x3mm, angled perpendicular to the tumor axis (as copied from 
the transverse T2W image) and aligned to the T2W image center. Ground-truth segmentations 
(i.e. manual segmentations from R1) were resampled to the same image space using a Nearest 
Neighbor interpolator. No restrictions were placed on the output image size.
Additional data augmentation consisting of random small geometric distortions was applied 
“on-the-fly” for the training cases. Furthermore image intensities were normalized and a fixed 
size patch approximating the full image size was extracted for both training and tuning cases to 
allow a forward pass of multiple cases in one minibatch. Full details of the data augmentation 
and preprocessing steps are provided in supplementary materials S1.
Neural network definition
We trained and evaluated the attention-gated U-Net (AG U-Net) as previously reported by 
Schlemper et al8, with an initial feature size of 16. We utilized the code shared by Schlemper et 
al., with some adaptation to allow multi-channel input and SimpleITK-based data augmentation. 
The network was trained on a NVIDIA GeForce RTX 2080Ti twice; once using the full multi-
sequence dataset (containing the T2W, DWI and ADC maps) and once using only T2W images. 
The network was optimized using the Sorensen-Dice loss function to address class imbalance 
between foreground and background voxels20 for 200 epochs. Hypertuning was applied 
to determine the optimum batch size, learning rate, optimizer algorithm and learning rate 
adaptation algorithm. Hypertuning was performed using only the train and tuning sets. 
Full details on the searched hyperspace are available in supplementary materials S2.
Statistical analysis
Baseline characteristics were compared among centers using one-way ANOVA for continuous 
variables and Kruskal-Wallis for categorical variables. Segmentations were inferred for the cases 
in the test set using the networks trained with optimum hyperparameters as determined by the 
performance in the tuning set. Network performance was defined as the agreement between 
network-inferred and expert reader’s manual segmentations (i.e. for R1 who segmented the 
whole dataset). Network performance was then compared to the inter-reader agreement 
between the two expert readers (for the 142 cases that were manually segmented by 2 
independent readers) as a “standard of reference”. Agreement was calculated using the DSC. 






























































































































































































































































































DSCs between the trained networks and expert-reader segmentations were compared using 
Wilcoxon signed rank test. Finally, the influence of DWI scan quality and tumor complexity 
scores were analyzed using Spearman correlation and by performing subgroup analyses by 
splitting the test set into poor vs. good scan quality (Likert score 1-3 vs 4), artefacts vs. no 
artefacts (score 1-3 vs 4) or complex vs easy to segment tumors (score 0-1 vs 2). 
Differences between subgroups were compared using Mann-Whitney U test.
Results
Study population
In total, 674 patient cases were considered for inclusion. After exclusion of 71 cases (Figure 1), 
the final study cohort included 603 cases, divided into training (n = 299), tuning (n = 61), 
and test datasets (n = 243). 376 patients were male, median age was 65 years (range 26-87). 
Clinical tumor stage at baseline was cT1-2 for 49 patients, cT3 for 480 and cT4 for 74 patients. 
499 patients had clinically node-positive disease. There were no significant differences in 
age, gender and cT stage distribution between the 6 centers (p=0.09-0.90), though cN stage 
distribution was significantly different (p<0.001). Between train, tune and test cohorts, 
there were no significant differences in age, gender and TN-stage distribution (p=0.07-0.88).
Network performance
The segmentation performance of the attention gated U-Net, using the segmentation from 
expert reader 1 as the ground truth, is shown in Table 2 and Figure 3A. The main network 
performance using the multisequence dataset was DSC 0.710 in the tuning set and DSC 0.669 
in the final test set. When compared to the inter-reader agreement between the expert 
radiologists as a standard of reference (for the 142 cases that were double-read in the 
test dataset), there was a statistically significant difference in DSC (p<0.001), though overall 
agreement was good for the network vs expert R1 (DSC 0.661) as well as between the two 
manual expert readers (DSC 0.749). Evolution of performance during training and effects of 
attention gating are described in Supplementary Figures S1 and S2.
When trained and tested using only T2W-MRI, network performance was significantly lower 
(Wilcoxon p<0.001): DSC 0.422 in the tuning set and DSC 0.314 in the test set, indicating a 
strong positive effect of the DWI/ADC data on the network’s performance. 
Influence of scan quality and tumor complexity
Effects of scan quality and tumor complexity are shown in Table 3 and Figures 3B-D. The 
performance of the deep learning network was significantly affected by overall DWI image 
quality (with lower performance in case of reduced SNR), but not by the severity of artefacts 
occurring around the tumor. Neither of these factors significantly affected expert inter-reader 
agreement. When selecting only good-quality scans based on the SNR score, the deep learning 
network performance was comparable to the expert inter-reader agreement (DSC 0.703 vs 
0.741, p=0.092). Tumor complexity had a significant effect on the performance of the deep 
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learning network as well as on expert inter-reader agreement, with more heterogeneous 
and irregular tumors (i.e. more complex and difficult to segment tumors) resulting in poorer 
segmentation performance and lower inter-reader agreement (DSC 0.703 versus 0.649 for the 
network and DSC 0.801 versus 0.712 between readers). Imaging examples showing the impact 
of DWI image quality and tumor complexity on the network’s performance and inter-reader 
agreement are shown in Figure 4.
Table 2. Network performance versus expert inter-reader agreement
DSC = Dice Similarity Coefficient, SD = Standard deviation. R1 and R2 are both board certified radiologists with >10 years’ 
experience in assessing rectal MRI. The multi-sequence network included T2W-MRI, high b-value DWI and ADC.
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Figure 3. Network performance vs inter-reader agreement. 
A) Full dataset. B) Impact of poor vs good SNR on DWI. C) Impact of DWI artefacts. D) Impact of tumor complexity.
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Table 3. Effects of DWI scan quality and tumor complexity
R1 and R2 are both board certified radiologists with >10 years’ experience in assessing rectal MRI. DWI image quality: poor 
SNR = Likert score 0-3, good SNR = score 4; Artefacts = score 0-3, no artefacts = score 4. Tumor complexity: complex = score 
0-1, easy = score 2. For further details of the different Likert scores see Figure 2.
Chapter 3
51
Figure 4. Imaging examples of impact of DWI image quality and tumor complexity on 
segmentation outcomes. A-C) Example of an easy to segment (score 2) tumor on a good quality DWI exam: T2-
weighted image (A), b1200 DWI (B) and ADC-map (C) of a homogeneous, well-demarcated tumor, resulting in good agreement 
between the network (blue) and both expert readers (R1 red, R2 green). D-F) Example of a complex tumor (score 0): T2-
weighted image (D), b800 DWI (E) and ADC-map (F) showing an irregularly shaped, heterogeneous tumor. There was moderate 
agreement between R1 (red) and R2 (green). Due to the poor tumor-to-background contrast on DWI, the network largely 
mis-segmented the tumor (blue). G-I) Example of a DWI scan with poor SNR (score 1): T2-weighted image (G), b750 DWI (H) 
and ADC-map (I) showing an small tumor in the upper rectum that is very difficult to discern on DWI owing to the low SNR of 
the image. Taking into account the anatomical T2-weighted images, inter-reader agreement for the two manual readers (red, 




In this study, we developed and analyzed a deep learning network to fully-automatically segment 
rectal tumors on MRI in a heterogeneous multiparametric MRI dataset of T2W, DWI and ADC-
maps from 6 different centers, intended as a representative clinical sample of MRIs acquired 
in routine practice. Performance of the network was compared to the inter-reader agreement 
between two independent expert radiologists, which was defined as the target performance 
level for the network as a standard of reference. 
Our results show that the network attained a good overall segmentation performance with 
a DSC of 0.669 in the independent test set. Although results remained statistically inferior, 
this performance level was almost in the range of the expert inter-reader agreement, which 
resulted in a DSC of 0.749. Both network performance and expert inter-reader agreement were 
correlated with tumor complexity, with more heterogeneous and poorly demarcated tumors 
resulting poorer segmentation outcomes and reduced inter-reader agreement. The network’s 
segmentation performance was also significantly influenced by DWI image quality, with poorer 
quality scans (in particular scans with a low SNR) resulting in poorer segmentation results. 
This effect was less evident for the two manual readers, probably because these readers relied 
more on the anatomical T2-weighted images for segmentation in cases where DWI quality 
fell short (as demonstrated in Figure 4E-F). Interestingly, when selecting only optimal-quality 
scans the network was able to achieve a performance comparable to that of expert inter-
reader agreement, highlighting the need for good quality image acquisition as a prerequisite for 
automated image analysis. Subgroup analysis using only T2W-MRIs clearly resulted in inferior 
segmentation performance (DSC 0.314 vs 0.669 for the full multiparametric dataset), 
indicating that DWI has significant added benefit when training computers to recognize and 
segment rectal tumors on MRI. Confirming the results of a previous study by Schlemper et al. 
(using CT data to segment pancreatic tumors), addition of attention gating allowed the network 
to successfully focus on the area of interest (i.e. the tumor) within the FOV8.
In a previous study including 140 patients from a bi-institutional dataset, Trebeschi et al.10 
investigated the use of a simple patch-based 2D convolutional network for rectal tumor 
segmentation on MRI. They achieved a network performance of DSC 0.68-0.70, which is 
similar to our current report including a more heterogeneous dataset. The use of a patch-
based approach in the study by Trebeschi resulted in slower inference and limited contextual 
information, with misclassification of rare imaging artefacts near the edge of the field of 
view. This was not observed as a limitation in our current study, as the U-Net only requires 
one forward pass to generate a segmentation, and better utilizes special context especially 
when using attention-gating. In another study by Wang et al. from 201812, a 2D U-Net showed a 
similar performance to expert reader agreement, with DSCs of 0.74 and 0.71, respectively, in a 
relatively small set of 93 cases using 10-fold cross-validation. In a similar study by Men et al.13, 
3 different deep learning architectures showed good performance using 5-fold cross-validation 
in a small set of 70 cases with DSC ranging from 0.70 to 0.78. However, no comparison was 
made to inter-reader agreement. Finally, in a recent study by Wang et al. from 201911, 
568 cases were included from several different centers to fine-tune and test a 2D ResNet with 
side-output, yielding a high remarkable performance of 0.84 DSC. Unfortunately inter-reader 
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agreement was again not reported, making it difficult to compare these results directly to ours. 
Interestingly, in the majority of the abovementioned previous works11–13, only T2W images were 
used as segmentation input. Though this eliminates the problem of addressing different spacing 
and registration errors between different sequences, we found that using only T2W images 
resulted in significantly poorer results compared to the multisequence dataset including also 
DWI/ADC. This is likely related to the intrinsic higher tumor-to-background ratio seen in DWI, 
which has previously been shown to produce lower inter-reader variations when segmenting 
rectal tumor volumes on MRI compared to T2W sequences21,22. 
To the best of our knowledge, this study is the first to explicitly assess the influence of scan 
quality and tumor morphology on the segmentation performance of deep learning networks 
aiming to account for variations in scan quality as well as overall “case mix” between and within 
centers that are bound to occur when applying such networks in daily clinical practice or on 
heterogeneous multicenter research datasets. We have learned that both the deep learning 
network as well as the manual readers struggled with segmenting morphologically complex 
tumors, i.e. tumors with a heterogeneous signal and ill-defined borders. These tumors (which 
constituted ±15-20% of our dataset) will likely always remain a bottle neck for segmentation. 
The segmentation performance of the network also suffered when the quality (SNR) of the 
DWI was low. This is an important factor to take into consideration when using MRI as input 
for automated tumor segmentation and stresses the need for protocol optimization. While T2 
image acquisition is relatively standardized, there are various methods of DWI image acquisition 
that may render highly variable quality images. Moreover, patient preparation (such as the 
reduction of intraluminal gas to avoid susceptibility effects18) is a known factor that may affect 
DWI image quality, in particular for DWI of the gastrointestinal tract. 
Our study design contained some limitations, which may warrant further study. First, in the 
absence of a true gold standard, we used the inter-reader agreement as the target level 
of performance for the network. Comparing the network’s segmentations to for example 
pathology slides may offer a more accurate ground truth, though this is generally not feasible, 
especially in retrospective studies. Second, given the highly time-consuming nature of the 
study, only a subset of cases was segmented by 2 readers (in order to compare the network’s 
results to inter-reader agreement). The network was, however, trained using the segmentation 
input of only one of these two readers, which can add a bias in the trained networks to the 
segmentation preference of this reader. In future studies, segmentations by multiple readers 
should be used as a form of data augmentation, with the aim of training reader-agnostic 
segmentation networks. Third, the DWI dataset included some cases (<10%) where the highest 
available b value was <800, which does not meet the current recommendations of the ESGAR 
consensus guidelines on rectal MRI which state that a clinical DWI protocol should include at 
least a high b value of ≥b80023. This may have resulted in poorer tumor-to-background contrast 
in these cases and may thus have had a potential negative effect on the network’s performance. 
Finally, cases from all included centers were present in the training, tune and test sets, with the 
intent to train the network to deal with heterogeneous data originating from different centers, 
thereby creating a more generalizable segmentation network. Though our final test set was 
independent in the sense that none of the cases were used to train the network, it did not 




In conclusion, this study demonstrated that despite large heterogeneity in data, it is possible to 
train a deep learning network to accurately segment rectal tumors on multiparametric MRI, with 
performance levels comparable to the overall agreement between expert radiologists, provided 
that DWI image quality is good. Once further optimized, such networks may significantly reduce 
the segmentation workload for future quantitative imaging studies and ultimately facilitate the 
implementation of segmentation tools in routine clinical practice.
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Abstract
Purpose:
Assess whether application of a micro-enema can reduce gas-induced susceptibility artefacts 
in Single-shot Echo Planar Imaging (EPI) Diffusion-weighted imaging of the rectum at 1.5T.
Materials and Methods:
Retrospective analysis of n=50 rectal cancer patients who each underwent multiple DWI-MRIs 
(1.5T) from 2012-2016 as part of routine follow-up during a watch-and-wait approach after 
chemoradiotherapy. From March 2014 DWI-MRIs were routinely acquired after application of a 
preparatory micro-enema (Microlax®; 5 ml; self-administered shortly before acquisition); 
before March 2014 no bowel preparation was given. In total, 335 scans were scored by 
an experienced reader for the presence/severity of air artefacts (on b1000 DWI), ranging 
from 0 (no artefact) to 5 (severe artefact). A score ≥3 (moderate-severe) was considered 
a clinically relevant artefact. A random sample of 100 scans was re-assessed by a second 
independent reader to study inter-observer effects. Scores were compared between the scans 
performed without and with a preparatory micro-enema using univariable and multivariable 
logistic regression taking into account potential confounding factors (age/gender, acquisition 
parameters, MRI-hardware, rectoscopy prior to MRI).
Results:
Clinically relevant air artefacts were seen in 24.3% (no micro-enema) vs. 3.7% (micro-enema), 
odds ratios were 0.118 in univariable and 0.230 in multivariable regression (P=0.0005 and 
0.0291). Mean severity score (±SD) was 1.19±1.71 (no-enema) vs 0.32±0.77 (micro-enema), 
odds ratios were 0.321 (P<0.0001) and 0.489 (P=0.0461) in uni- and multivariable regression, 
respectively. Inter-observer agreement was excellent (κ0.85).
Conclusion:
Use of a preparatory micro-enema shortly before rectal EPI-DWI examinations performed 
at 1.5T MRI significantly reduces both the incidence and severity of gas-induced artefacts, 
compared to examinations performed without bowel preparation.
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Introduction
Diffusion-weighted imaging (DWI) is nowadays increasingly adopted as an integral part of 
oncologic imaging protocols. In rectal cancer, DWI has mainly shown its value for response 
evaluation and follow-up of rectal tumors after chemoradiotherapy, specifically for the 
discrimination of viable tumor within areas of post-radiation fibrosis1–4.
The most commonly used sequence for abdominal diffusion imaging is a single-shot Echo 
Planar Imaging (EPI) sequence. The main benefit from an EPI approach is its short acquisition 
time, which minimizes the risk of motion artefacts. However, an important drawback is that 
EPI sequences are prone to susceptibility artefacts, particularly at higher field strengths5,6. 
Susceptibility artefacts are changes or distortions in image signal caused by local magnetic field 
inhomogeneities, for example due to the presence of metal objects (e.g. hip replacements or 
surgical clips). In bowel imaging, these artefacts are mainly caused by the presence of gas in 
the rectal lumen. In a study by Caglic et al. (in prostate MRIs) it was reported that increased 
rectal gas-distension correlates significantly with reduced DWI image quality and increased 
DWI artefacts7. Particularly when the bowel itself is the organ under investigation, gas-induced 
susceptibility artefacts can severely reduce the diagnostic image quality, in some cases even 
rendering the images non-diagnostic. In published reports on bowel DWI 4-11% of patients had 
to be excluded from analyses due to poor DWI scan quality8–11.
To reduce the influence of these artefacts on image quality, two main strategies can be 
employed: 1) change the acquisition parameters (i.e. type of DWI sequence) or 2) remove the 
cause of the artefact.
So far, most published studies have focused on the first approach and tested alternative ways 
of DWI image acquisition such as parallel imaging12, smaller Field of View (FOV)13 or bipolar DWI 
acquisition14. A potential solution to remove the cause of the artefact is to reduce the amount 
of gas in the rectal lumen by rectal filling, where the rectum is filled with a liquid 
(such as ultrasound gel) prior to image acquisition, replacing the gas. However, a potential 
downside of this approach is that it causes distension of rectum and compression of the 
surrounding mesorectal fat15,16, potentially hampering correct assessment of the relation 
between the tumor and mesorectal fascia17. Use of endorectal filling is therefore not 
routinely recommended18.
An alternative potential solution is the application of a preparatory micro-enema shortly prior 
to image acquisition. A micro-enema can typically be self-administered by the patient to reduce 
the amount of gas (and stool) in the rectum.
The aim of this study was to test this hypothesis and investigate to what extend the use of a 





The study was approved by the local institutional review board. Due to the retrospective nature 
of the study, informed consent was not required.
Patients
We retrospectively selected 50 consecutive rectal cancer patients (66% male, mean age 
63) who each underwent serial MR imaging including an EPI-DWI sequence of the rectum as 
part of their routine follow-up during a ‘watch-and-wait’ policy between January 2012 and 
February 2016 at Maastricht University Medical Center (MUMC). All patients had previously 
been treated with long-course chemoradiotherapy and were non-operatively managed due 
to strong clinical evidence of a clinical complete response. The follow-up protocol included 
regular MRI performed 3 monthly in the first year and 6 monthly in the second to fifth year of 
follow-up. In March 2014, use of a rectal micro-enema (Microlax®, McNeil Healthcare, Ireland) 
was introduced into the routine protocol. Inclusion criteria consisted of: 1) availability of at 
least 2 consecutive follow-up MRIs including a EPI-DWI sequence, with at least 1 MRI without 
bowel preparation and 1 MRI after application of a micro-enema , 2) no treatment (radiation 
or surgery) performed between the various sequential scans, 3) no history of hip replacement 
surgery (as hip prostheses will results in artefacts on DWI, as a result of which the presence of 
air artefacts cannot be sufficiently studied).
Image acquisition and patient preparation
All MR images were acquired on a 1.5T MR system (Intera (Achieva) or Ingenia MR system; 
Philips Healthcare, Best, The Netherlands) using a phased-array body coil. The routine protocol 
included T2-weighted turbo spin echo sequences in 3 planes (sagittal, axial and coronal) and an 
axial EPI-DWI sequence with b=1000 being the highest b-factor. The transverse T2-weighted 
and DW-sequences were angled perpendicular to the former tumor axis (i.e. the fibrotic 
remnant) as visualized on the sagittal planning scan. Image angulation was consistent over time 
for the various follow-up scans. Detailed sequence parameters of the DWI-sequences used 
during the study period are provided in Table 1. For the scans performed with a preparatory 
micro-enema (from March 2014), the micro-enema consisted of a 5 ml solution, that was self-
administered by the patients ±15 minutes prior to acquisition. Apart from the micro-enema no 
bowel preparation or spasmolytic agents were applied.
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Table 1. DWI sequences used during the study period
FOV = Field of View, AP = Anterior-Posterior, SPIR = Spectral Presaturation with Inversion Recovery, 
SPAIR = Spectral Attenuated Inversion Recovery.
* Only the b1000 images were used for image evaluation in the current study.
Image assessment
In total 335 scans (in 50 patients) were analyzed by an experienced reader (DMJL) who scored 
the presence and severity of gas-related susceptibility artefacts using a 6-point score (0 = no 
artefact, 1 = mild artefact, 2 = mild – moderate artefact, 3 = moderate artefact, 4 = moderate – 
severe artefact, 5 = severe artefact). The scoring system with representative imaging examples 
is illustrated in Figure 1. 
A second experienced reader (JJMVG) independently analyzed a random sample of n=100 
scans (50 scans without preparation, 50 scans after application of a micro-enema) using the 
same scoring system to study inter-observer effects. Both readers were blinded to clinical 




Figure 1. Artefact severity score. The severity of gas-induced susceptibility artefacts was scored on b1000 
DWI using a 6-point scale ranging from ‘no artefacts’ to ‘severe artefacts’. Artefacts with a score of ≥3 were considered 
clinically relevant artefacts, i.e. artefacts rendering the images to be of insufficient diagnostic quality for adequate clinical 
image interpretation. (A) Good visualization of the rectal wall and rectal lumen without any visible artefacts, (B) mild distortion 
of the rectal wall, (C) limited signal pile-up overlapping with the anterior rectal wall (arrow), (D) marked image distortion due 
to which the rectal wall cannot properly be assessed, (E) marked distortion combined with significant signal pile-up anteriorly 




The study outline is graphically illustrated in Figure 2: to assess the effect of the introduction 
of the preparatory rectal micro-enema on DW image quality, the presence and severity of gas-
related artefacts were compared between the scans acquired between January 2012 and March 
2014 (= ‘without micro-enema’) and scans acquired between July 2014 and February 2016 
(= ‘with micro-enema’). Scans acquired between March 2014 and July 2014 (the transit period) 
were excluded from the analyses as in this period some patients may not yet have received the 
micro-enema routinely. Primary outcome was the proportion of ‘clinically relevant’ artefacts 
in the no micro-enema versus micro-enema scans. Artefacts were considered to be clinically 
significant if they would considerably hamper clinical DW image interpretation and were defined 
for the purpose of this study as artefacts with a severity score of ≥3 (moderate, moderate-
severe and severe). The artefact severity score itself was assessed as a secondary outcome. 
The influence of potential confounding factors was assessed using univariable and multivariable 
logistic regression with a binary outcome for the primary outcome (clinically relevant artefact 
yes/no) and ordinal logistic regression for the secondary outcome (6-point severity score). 
Generalized linear models with generalized estimating equations for clustered data were 
applied, with scans clustered by patient. The working correlation was exchangeable for the 
binary logistic regression19 and independent for the ordinal logistic regression. A p-value of 
<0.05 was considered significant. Results for the binary logistic regression differed very little 
when an independent working correlation was used. Inter-observer agreement was assessed 
using quadratic weighted Cohen’s Kappa (0-0.20 = poor, 0.21-0.40 = fair, 0.41-0.60 = moderate, 
0.61-0.80 = good and 0.81-1.00 = excellent agreement). Statistical analysis was performed using 
the Statistical Package for the Social Sciences (SPSS version 23.0, IBM® SPSS® Inc. Chicago, IL) 
and Statistics Analysis Software (SAS version 9.4, SAS® Institute Inc., Cary, NC).
Figure 2. Study outline. Fifty patients were included. In these patients, 226 scans were acquired from January 
2012-March 2014 without any bowel preparation (the no micro-enema group). From July 2014-February 2016, 109 scans 
were acquired with a preparatory micro-enema (the micro-enema group). Scans made in the transition period after the 
introduction of the micro-enema (March 2014-July 2014; n=29) were excluded from the analysis.
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Table 2 shows the baseline study characteristics. The 50 study patients together underwent 
a total of 364 DWI-MRI examinations. Twenty-nine scans from the transit period after the 
introduction of the micro-enema (March 2014-June 2014) were excluded. This left a total of 
335 scans for analysis (mean 6.7 examinations per patient, range 2-10), of which 226 (67.5%) 
were acquired without a micro-enema (before March 2014) and 109 (32.5%) were acquired 
with a micro-enema (after June 2014).
Table 2. Baseline characteristics and results for the scans 
performed without and with a preparatory micro-enema
* At the time of image acquisition.




Agreement between the two readers for the use of the 6-point artefact severity score 
(illustrated in Figure 1) was excellent with a weighted Kappa of 0.85 
(95% confidence interval 0.77-0.94).
Figure 3. Results. Boxplots comparing the presence of clinically relevant artefacts (A) and the artefact severity score 
(B) between the scans acquired without bowel preparation and after application of a preparatory micro-enema.
Effect of micro-enema on DW image quality
Figure 3 compares the number of clinically relevant artefacts and the severity of artefacts 
between the group of scans without and with a micro-enema. In the group without a micro-
enema, clinically relevant artefacts (severity score ≥3) occurred in 55/226 (24.3%) scans versus 
4/109 scans (3.7%) in the group with a micro-enema (Fig 3a). The reduction in the number 
of clinically relevant artefacts was significant with an odds ratio (OR) of 0.118 (P=0.0005) in 
univariable binary logistic regression analysis and an OR of 0.230 (P=0.029) in multivariable 
analysis. The overall artefact severity score was also higher in the group without a micro-enema 
(Fig 3b), with a mean severity score of 1.19 (± 1.71), compared to 0.32 (± 0.77) in the scans 
acquired with a micro-enema. The reduction in the severity of artefacts was significant with 
an OR of 0.321 (P<0.0001) in univariable ordinal logistic regression analysis and an OR of 0.489 
(P=0.046) in multivariable analysis.
Of all available variables to adjust for confounding, b-values, acquisition matrix size, flip angle, 
Number of Signals Averaged, Field of View (FOV) right-left and anterior-posterior, and water-
fat shift were excluded because they were either collinear or highly correlated with another 
variable (correlation coefficient > 0.8). The remaining variables (gender, age at scan time, 
repetition time, echo time, FOV cranial-caudal, EPI factor, fat saturation technique, MRI-






































multivariable models. When these variables, including those excluded due to high correlation, 
were added to a model with the micro-enema effect one by one, no substantial confounding 
was observed (Table 3).
Detailed results of the uni- and multivariable analyses are provided in Table 3. A representative 
example of how gas-related artefacts reduced over time after the introduction of the routine 
use of a micro-enema is provided in Figure 4 for a patient scanned both without preparation 
and after application of a micro-enema.
Table 3. Results from uni- and multivariable logistic regression
NB. CI = Confidence Interval. Results were clustered by patient, since patients contribute multiple scans.
† Binary logistic regression, ‡ Ordinal logistic regression
Confounders indicated with an * were included in the multivariable analysis
ⱡ All scans were performed on 1.5T using either a Intera (Achieva) or Ingenia MRI system from Philips
# All scans were performed using either Spectral Presaturation with Inversion Recovery (SPIR) or Spectral Attenuated 
Inversion Recovery (SPAIR).
± Scans were performed with 2, 3, 6 or 7 b-values, the highest b-value (used for evaluation) always being b1000, see Table 1
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Figure 4. Examples. Example of the b1000 DWI (A,B) and corresponding T2-weighted images (C, D) of a patient in 
whom a severe artefact was observed on a scan without bowel preparation (A, C), and no artefact was observed on a later 
follow-up scan after application of a micro-enema (B, D). All images show the rectum at the level of the uterus (*). On DWI 
without an enema (A) there is marked signal pile-up (arrows) and pronounced image distortion, due to which the rectal wall 
cannot be assessed. The corresponding T2W image (C) shows a substantial amount of gas in the rectal lumen (arrow). 
On the later follow-up DWI scan performed after a preparatory micro-enema (B), there are no artefacts and the rectal wall 





The results of our study show that the application of a preparatory micro-enema shortly 
before image acquisition significantly reduces both the incidence as well as the severity of gas-
induced susceptibility on rectal DWI performed at 1.5T. The use of a micro-enema reduces the 
proportion of rectal DWI scans suffering from clinically relevant artefacts – i.e. artefacts that 
hamper clinical image interpretation – from 1 in every 4 scans to 1 in every 20 scans, thereby 
offering a substantial potential clinical benefit in terms of improved diagnostic image quality.
To our knowledge only one previous study specifically reported on the use of an enema for 
the reduction of susceptibility artefacts on DWI. In this study by Lim et al.20, diagnostic image 
quality of multiparametric MRI of the prostate was compared at 3.0T in patients without bowel 
preparation versus patients who were instructed to self-administer an enema on the morning 
of the day they received their MRI examination. Interestingly, while application of an enema 
resulted in significantly less stool and gas in the rectum, no significant difference was found in 
the diagnostic quality of the enema group compared to the no-preparation group. 
These seemingly conflicting results may be in part caused by the small number of scans 
assessed (n= 60, compared to over 300 scans in the current report), with a relatively low 
number of events (severe artefacts) ranging from 1-7 per group. Another possible explanation 
is the timing of the enema, which was self-administered in the morning of the day of the 
examination in the study by Lim et al., compared to 15-30 minutes prior to examination in our 
study. Finally the target organ under investigation in the study of Lim was the prostate and not 
the rectum itself. Various alternative methods to reduce artefacts have been reported, 
most of which focus on making the EPI sequences more robust. An example is the use of 
parallel imaging techniques. Parallel imaging allows for less phase-encoding steps, thereby 
reducing both sensitivity to artefacts and acquisition time12. In our study parallel imaging was 
also employed (factor 2.0). An alternative option is reducing the FOV, allowing for a higher 
spatial resolution in the phase-encoding direction, where the EPI sequence is most influenced 
by the susceptibility artefacts. Korn et al.13 assessed the use of reduced FOV-excitation in DWI 
for prostate cancer detection using a 5 point scale for image distortion and showed that the 
reduced FOV significantly reduced image distortion scores by 0.48-0.56 points. Thian et al.21 
explored the use of a read-out segmented (rs) EPI Sequence, in which the k-space is filled 
in several segments (as opposed to a standard single shot technique). In n=30 pelvic DWI 
examinations, lesion conspicuity was significantly better and geometric distortions significantly 
less on the rs-EPI sequence. The reported magnitude of effect of these technical alterations 
was less than that of the use of a preparatory micro-enema (combined with parallel imaging) 
in our study. Although with this approach we could already reduce the number of clinically 
relevant artefacts to less than 5%, future research should focus on further optimizing scan 
quality by combining patient preparation with artefact reduction acquisition techniques such 
as the examples described above to ultimately offer the best possible DWI protocols with 
stable and robust diagnostic image quality, on which radiologist may truly rely on for diagnostic 
decision making. Although we did not perform formal questionnaires to objectively quantify the 
degree of patient discomfort for the self-administration of the micro-enema, in our experience 
patients tolerated it very well and considered it a minimal extra burden.
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There are some limitations to our study design. First, we fully acknowledge that an important 
drawback of our study design is that none of the study patients had rectal tumors in situ at 
the time of image acquisition, making it impossible to study effects of artefact reduction on 
lesion conspicuity. All MRIs were performed in patients with a clinical complete response who 
underwent multiple follow-up MRIs (3 to 6-monthly) for a longer time period. We chose this 
approach as a first exploratory step as it offered the benefit of a consistent clinical setting (in 
which patients underwent no therapeutic procedures in between scans that may influence 
image quality) which creates the unique opportunity to perform within patient comparisons, 
thereby reducing effects of interpatient variability. The obvious next step will be to study the 
clinical benefit of our approach in the staging and restaging setting to determine effects on 
lesion conspicuity and staging outcomes. Second, all MRIs were performed at 1.5T. It would be 
interesting to see how the results of our study translate to 3.0T where susceptibility effects will 
typically be more severe22 and the gain of applying a micro-enema may thus be more profound. 
Third, a substantial number of patients underwent flexible rectoscopy just prior to the MRI, 
because they were in a follow-up protocol that included MRI and rectoscopy on the same day. 
During this procedure gas is introduced into the rectum, which may have negative effects on 
MR image quality when performed shortly afterwards. On the other hand, the endoscopists 
in our center typically perform a de-sufflation of the rectum, whilst removing the endoscope 
which will reduce the amount of gas in the lumen. Moreover, the fact that patients underwent 
rectoscopy just before their MRI did not have a significant confounding effect in our statistical 
analyses. Finally, the artefacts in this study were assessed using a more or less subjective scoring 
system focusing on overall diagnostic image quality. In order to reduce subjectivity we however 
used a standardized 6-point scoring system which led to excellent interobserver agreement 
between two independent readers (κ0.85).
In conclusion, the use of a preparatory micro-enema shortly prior to image acquisition 
significantly reduces both the incidence and severity of gas-related susceptibility artefacts 
in DWI of the rectum performed at 1.5T. A preparatory micro-enema can easily be self-
administered just minutes before the MR examination. As such we believe that – when DWI 
forms an integral part of the imaging assessment of the rectum – a micro-enema should be 
considered, as it provides a significant benefit to the image quality at a relatively small cost in 
terms of preparation time and patient discomfort.
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Abstract
Radiomics aims to quantify phenotypic characteristics on medical imaging through the use 
of automated algorithms. Radiomic artificial intelligence (AI) technology, either based on 
engineered hard-coded algorithms or deep learning methods, can be used to develop non-
invasive imaging-based biomarkers. However, lack of standardized algorithm definitions and 
image processing severely hampers reproducibility and comparability of results. To address 
this issue, we developed PyRadiomics, a flexible open-source platform capable of extracting a 
large panel of engineered features from medical images. PyRadiomics is implemented in Python 
and can be used standalone or using 3D-Slicer. Here, we discuss the workflow and architecture 
of PyRadiomics and demonstrate its application in characterizing lung-lesions. Source code, 
documentation, and examples are publicly available at www.radiomics.io. With this platform, 
we aim to establish a reference standard for radiomic analyses, provide a tested and maintained 
resource, and to grow the community of radiomic developers addressing critical needs in 
cancer research.




Medical imaging is considered one of the top innovations that transformed clinical cancer 
care, as it significantly changed how physicians measure, manage, diagnose, and treat cancer. 
Imaging is able to noninvasively visualize the radiographic phenotype of a tumor before, during, 
and after treatment. Radiomics refers to the comprehensive and automated quantification of 
this radiographic phenotype using data-characterization algorithms1–3. Radiomics can quantity 
a large panel of phenotypic characteristics, such as shape and texture, potentially reflecting 
biologic properties like intra- and inter-tumor heterogeneities4. 
Radiomic technologies, based on artificial intelligence (AI) methods, are either defined using 
engineered hard-coded features, which often rely on expert domain knowledge, or on deep 
learning methods, which can learn feature representations automatically from data5. The 
potential of radiomics has been shown across multiple tumor types, including brain, head-
and-neck, cervix, and lung cancer tumors. Furthermore, these data, extracted from MRI, PET 
or CT images, were associated with several clinical outcomes, and hence, potentially provide 
complementary information for decision support in clinical oncology1.
However, there is a lack of standardization of both feature definitions and image processing, 
which has been shown to have a substantial impact on the reliability of radiomic data6–8. 
Furthermore, many studies use in-house developed software, often not shared with the public, 
making the reproduction and comparison of results difficult.
To address this issue, we developed a comprehensive open-source platform, called 
PyRadiomics, which enables processing and extraction of radiomic features from medical image 
data using a large panel of engineered hard-coded feature algorithms. PyRadiomics provides 
a flexible analysis platform with both a simple and convenient front-end interface in 3D Slicer, 
a free open-source platform for medical image computing9, as well as a back-end interface 
allowing automation in data processing, feature definition, and batch handling. PyRadiomics 
is implemented in Python, a language that has established itself as a popular open-source 
language for scientific computing, and can be installed on any system. 
Here, we discuss the workflow and architecture of PyRadiomics and demonstrate its application 
in characterizing benign and malignant lung lesions. Source code, documentation, instruction 
videos (see Video 1 and 2), and examples are available at www.radiomics.io/pyradiomics.html. 
With this resource, we aim to establish a reference standard for radiomic analyses, provide a 
tested and maintained open-source platform, and raise the awareness among scientists of the 
potential of radiomics technologies.
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Figure 1. A Overview figure of the process of PyRadiomics. First, medical images are segmented. Second, features 
are extracted using the PyRadiomics platform, and third, features are analyzed for associations with clinical or biologic 
factors. B Stability of radiomics features for variation in manual segmentations by expert radiologists. C Heatmap showing 
expression values of radiomics features (rows) of 429 lesions (columns). Note the four subtypes that could be identified from 
the expression values and their associations with malignancy. D Area under curve (AUC) showing the performance of the 




The PyRadiomics platform can extract radiomic data from medical imaging (such as CT, PET, 
MRI) using four main steps: I) Loading and preprocessing of the image and segmentation maps, 
II) Application of enabled filters, III) Calculation of features using the different feature classes, 
and IV) Returning results. See Figure 1A for an illustration of this process.
I) Loading and preprocessing: In this step, medical images (e.g. CT, PET, MRI) and segmentation 
maps (e.g. performed by radiologist) will be loaded into the platform. The large majority of 
image handling is done using SimpleITK, which provides a streamlined interface to the widely 
used open-source Insight Toolkit (ITK)10. This enables PyRadiomics to support a wide variety 
of image formats, while also ensuring that much of the low-level functionality and basic image 
processing is thoroughly tested and maintained. For texture and shape features, several 
resampling options are included to ensure isotropic voxels with equal distances between 
neighbouring voxels in all directions. 
II) Filtering: Features can be calculated on the original image or on images pre-processed using 
a choice of several built-in filters. These include wavelet and laplacian of gaussian (LoG) filters, 
as well as several simple filters, including square, square root, logarithm, and exponential filters. 
For the application of the wavelet and LoG filter, the platform makes use of the PyWavelets and 
SimpleITK, respectively. The remaining filters are implemented using NumPy. 
III) Feature calculation: The platform contains five feature classes: a class for first-order 
statistics, a class for shape descriptors, and texture classes Gray Level Co-occurrence Matrix11, 
Gray Level Run Length Matrix12,13, and Gray Level Size Zone Matrix14. All statistic and texture 
classes can be used for feature extraction from both filtered and unfiltered images. Shape 
descriptors are independent from intensity values and therefore can only be extracted from 
unfiltered images. Feature extraction is supported for both single slice (2D) and whole volume 
(3D) segmentations. 
IV) Results: Calculated features are stored and returned in an ordered dictionary. Every feature 
is identified by a unique name consisting of the applied filter, the feature class and feature 
name. Besides the calculated features, this dictionary also contains additional information on 
the extraction, including current version, applied filters, settings, and original image spacing.
To enhance usability, PyRadiomics has a modular implementation, centered around the 
featureextractor module which defines the feature extraction pipeline and handles interaction 
with the other modules in the platform. All feature classes are defined in separate modules. 
Furthermore, all are inherited from a base feature extraction class, providing a common 
interface. Finally, the platform contains two helper modules, generalinfo that provides additional 
extraction information included in the returned result, and the imageoperations module that 
implements the functions used during image preprocessing and filters.
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Aside from interactive use in Python scripts through the featureextractor module, PyRadiomics 
supports direct usage from the command line. There are two scripts available, pyradiomics and 
pyradiomicsbatch, for single image and batch processing, respectively. For both scripts, an 
additional parameter file can be used to customize the extraction and results can be directly 
imported into many statistical packages for analysis, including R and SPSS. Additionally, a 
convenient front-end interface for PyRadiomics is provided as the ‘radiomics’ extension within 
3D Slicer. All code, including the Slicer extension, documentation, frequently asked questions, 
and instruction videos (see Video 1 and 2) are available at www.radiomics.io/pyradiomics.html. 
In the supplementary information detailed descriptions of feature definitions, dataset, 
and analyses can be found. 
Case Study
In a case study, we demonstrated an application of PyRadiomics for lung lesion characterization 
to discriminate between benign and malignant nodules. We used the publicly available cohort 
of the Lung Image Database Consortium (LIDC-IDRI)15, which consists of diagnostic and lung 
cancer screening CT scans along with marked-up annotated lesions and per-lesion malignancy 
rating (i.e. if a nodule is benign or malignant) from experienced radiologists (Supplementary 
Methods 1). From 302 patients, we included 429 distinct lesions in our analysis, each with four 
volumetric segmentations and malignancy ratings. In total, 1120 radiomic features (14 shape 
features, 19 first-order intensity statistics features, 60 texture features, 395 LOG features and 
632 wavelet features) were extracted from all four delineations of every lesion 
(Supplementary Methods 2-4). 
To assess the effect variations in the manual segmentations on radiomic feature values, we 
calculated the stability for each of the features extracted from four segmentations performed 
by expert radiologists. This stability was calculated using intraclass correlation coefficient (ICC) 
(Figure 1B). High stability (median ± sd: ICC > 0.8 ) was observed for LOG (ICC= 0.91 ± 0.11), 
first-order intensity statistics (ICC= 0.88 ± 0.13) and texture features (ICC= 0.91 ± 0.11), whereas 
shape (ICC= 0.60 ± 0.31) and wavelet (ICC= 0.63 ± 0.23) features showed moderate stability, 
which indicates their sensitivity towards delineation variability. 
Selecting all features with high stability (ICC>0.8), resulted in 535 radiomic features (5 shape 
features, 14 first-order intensity statistics features, 48 texture features, 310 LOG features and 
158 wavelet features). Figure 1C displays unsupervised clustering of the standardized expression 
values of the 535 stable radiomic features (rows) in 429 nodules (columns). We observed 
four distinct clusters of lesions with similar expression values. Comparing these clusters with 
lesion malignancy status, we observed significant difference between them (P = 2.56e−24, χ2 
test). 92% (n= 81) of the samples of cluster S1 (n = 88) were malignant, whereas 95% (n = 38) 
of the samples of cluster S2 (n = 40) were benign. For cluster S3 (n = 143) and S4 (n = 158) the 
proportion of malignant samples were 54% (n = 78) and 34% ( n = 53) respectively. 




In order to evaluate the performance of a multivariate imaging biomarker, we divided the cohort 
into training (n=214) and validation (n=215). Using minimum Redundancy Maximum Relevance 
(mRMR), we selected 25 stable radiomic features from the training cohort (Supplementary 
Table 1). An multivariate biomarker was developed by fitting selected features into a random 
forest classifier, based on the training data. The biomarker demonstrated strong and 
significant performance to characterize lung nodules (AUC=0.79 [0.73-0.85], Noether test 
p-value=4.12e-22) on the validation cohort (Figure 1D). More details on features extraction and 
analysis methods are provided in the Supplements.
Conclusion
PyRadiomics provides a flexible radiomic quantification platform, with a simple and convenient 
front-end interface in 3D Slicer, as well as a back-end interface within Python allowing 
automation in data processing, feature definition, and batch handling. By providing a tested 
and maintained open-source radiomics platform, we aim to establish a reference standard 
for radiomic analyses promoting reproducible science within the quantitative imaging field, 
raise awareness among scientists of this platform to support their work, and to provide a 
practical go-to resource. By doing so, we hope to grow the community of radiomic technology 
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Abstract
Purpose
To compare the performance of advanced Radiomics analysis to morphological assessment by 
expert radiologists to predict a good or complete response to chemoradiotherapy in rectal 
cancer using baseline staging MRI.
Materials and methods
We retrospectively assessed the primary staging MRIs (prior to chemoradiotherapy (CRT)) of 
133 rectal cancer patients from 2 centers. First, two expert-radiologists subjectively estimated 
the likelihood of achieving a “complete response” (ypT0) and “good response” (TRG 1-2), using 
a 5-point score (based on TN-stage, MRF/EMVI-status, size/signal/shape). Next, tumor volumes 
were segmented on high b-value DWI (semi-automated, corrected by 2 non-expert and 
2-expert readers, resulting in 5 segmentations), copied to the remaining sequences after which 
a total of 2505 radiomic features were extracted from T2W, low and high b-value DWI and ADC. 
Stability of features for noise due to inter-reader and inter-scanner and protocol variations was 
assessed using intraclass correlation (ICC) and the Kruskal-Wallis test. Using data from center 1 
(n=86; training set), top 9 features were selected using minimum-Redundancy Maximum-
Relevance and combined in a logistic regression model. Finally, diagnostic performance of the 
fitted models was assessed on data from center 2 (n=47; validation set) and compared to the 
performance of the radiologists. 
Results
The Radiomic models resulted in AUCs of 0.69-0.79 (with similar results for the segmentations 
performed by expert/non-expert readers) to predict response, results similar to the 
morphologic prediction by the expert-radiologists (AUC 0.67-0.83). Radiomics using semi-
automatically generated segmentations (without manual input) did not result in significant 
predictive performance. 
Conclusions
Radiomics could predict response to therapy with comparable diagnostic performance as 
expert radiologists, regardless of whether image segmentation was performed by non-expert or 
expert readers, indicating that expert input is not required in order for the Radiomics workflow 
to produce significant predictive performance.
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Introduction
According to current standard of care, patients with very distal and/or locally advanced rectal 
tumors (≥T3 and/or N+) typically receive neoadjuvant chemoradiotherapy (CRT) aiming to 
achieve downstaging and thereby increasing the chance of a complete surgical resection. As a 
result of CRT, approximately 15% of patients undergo a complete tumor response1. There is a 
current paradigm shift in treatment towards considering organ-preservation (‘watch-and-wait’) 
for these very good responders1–3. In addition to assessing response after completion of CRT to 
select these patients, there is also an increased clinical interest in the prediction of treatment 
response before the start of CRT. In patients likely to respond well, neoadjuvant treatment may 
be intensified, for example with an additional radiotherapy boost, to increase the chance of 
organ preservation. Patients with smaller tumors have a higher response rate4,5, but according 
to current standards are typically treated with direct surgery without CRT. However, with a 
predicted high response rate chemoradiation might be offered to these small tumors as an 
alternative with the sole aim to achieve organ preservation, whereas patients with radioresistant 
tumors remain better off with surgery alone, which is the current standard treatment for 
these tumors. To date, such an approach is obviously still experimental and offered only in 
trial settings, for example within the STAR-TREC study, a collaborative phase II trial on CRT + 
organ-preservation for early rectal cancer running in the UK, Denmark and the Netherlands 
(ClinicalTrials.gov NCT02945566)6.
Several studies have shown that imaging may play a role in the pre-treatment prediction of 
response, with a particular focus on MRI being one of the main imaging modalities used to stage 
rectal cancer. “Semantic features” including the T-stage, N-stage, Circumferential Resection 
Margin (CRM), Extra-Mural Venous Invasion (EMVI) and baseline tumor volume have been 
shown to be associated with the chance of response to varying degrees7–10. Promising (though 
inconsistent) results have also been reported for the use of more novel functional MR imaging 
sequences such as diffusion-weighted imaging (DWI) and dynamic contrast enhanced (DCE) 
MRI, that can provide quantifiable information on biological tumor properties such as tumor 
cellularity and tumor perfusion11–13.
Another highly interesting recent development is Radiomics, a high-throughput post-
processing technique capable of extracting large numbers of quantitative “features” from 
routinely acquired medical imaging14. These features can be used to generate a comprehensive 
radiologic phenotype and can potentially provide us with new insights into underlying biologic 
tumor characteristics15–17. In rectal cancer, a handful of studies investigating Radiomics for 
response prediction have shown promising results18–20, albeit mainly in relatively small single 
center cohorts. So far, no studies exist that have compared the use of Radiomics to subjective 
estimation of the likelihood of response by radiologists based on an overall visual interpretation 
of the local tumor stage at baseline MRI. Such a comparison would be an interesting step to 
provide at least some preliminary perspective on the potential added benefit from Radiomics in 
a clinical setting. Moreover, data published so far has mainly been based on relatively small and 
single center study cohorts.
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With this study we aim to add to previous research by investigating the potential of Radiomics 
to predict treatment response in rectal cancer using the baseline staging MRI data from 
two institutions (to allow a test and validation dataset and to study effects of acquisition 
heterogeneity) and by comparing the performance of Radiomics to morphological assessment 
of the images by expert radiologists to provide a first exploratory estimation of its potential 
clinical benefit.
Methods and Materials
The study was approved by the local institutional review board (of both institutions). Due to the 
retrospective nature of the study, informed consent was waived.
Study population
We retrospectively identified 133 patients with rectal cancer who underwent long course 
chemoradiotherapy at one of two study centers (Maastricht University Medical Center and 
Zuyderland Medical Center Heerlen) between March 2007 and January 2013. Main inclusion 
criteria were (a) histologically proven primary non-mucinous type rectal adenocarcinoma, 
(b) locally advanced disease (≥cT3 and/or N+ disease), (c) neoadjuvant treatment consisting of 
28 fractions of 1.8 Gy radiotherapy with concurrent capecitabine 825 mg/m2 chemotherapy, 
(c) availability of a multiparametric pre-treatment MR examination including a T2-weighted 
sequence, a diffusion-weighted sequence and corresponding quantitative ‘apparent diffusion 
coefficient’ (ADC) map, and (d) availability of either histology after surgery or long-term (> 2 
years) follow-up in case of a wait-and-see program to establish the final treatment response.
Image acquisition
All patients received a primary staging MRI on a 1.5T MR system (Intera or Ingenia MR system; 
Philips Healthcare, Best, The Netherlands in center 1; Magnetom Avanto; Siemens in center 2).
The imaging protocol included a T2-weigthed turbo spin echo sequence in sagittal, coronal and 
transverse plane and a transverse EPI-DWI sequence with 1000 or 1100 s/mm2 as the highest 
b-value. Detailed sequence parameters are provided in Table 1. ADC maps were calculated 
from the DWI sequences using a mono-exponential model including all available b-values. 
Oblique transverse T2W and DWI sequences were acquired in identical planes perpendicular 
to the tumor axis as seen on the sagittal T2W scan. The transverse T2-weighted, low b-value 
DWI (DWIb0), high b-value DWI (DWIb1000/b1100) images and the ADC maps were used for radiomic 
feature extraction.
Standard of reference / clinical outcome
The main clinical study outcomes were:
(1) the prediction of a complete versus incomplete response after chemoradiotherapy. 
(2) the prediction of a good versus poor response after chemoradiotherapy. 
The final histopathologic tumor stage after surgery including the tumor regression grade (TRG) 
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according to Mandard21 served as the main standard of reference. For the first study outcome, 
patients with a ypT0 / TRG1 were classified ‘complete responders’, while patients with residual 
tumor (ypT1-4, TRG 2-4) were classified as ‘incomplete responders’. For the second outcome, 
patients with a TRG1-2 (indicating predominant fibrosis) were classified as ‘good responders’ 
and patients with TRG3-5 as ’poor responders’. For N=13 patients who underwent wait-and-
see without surgery, a sustained clinical complete response for >2 years follow-up (i.e. no signs 
of recurrence on follow-up MRI and endoscopy performed 3 monthly in the first year and 
6-monthly in the following years) was used as a surrogate endpoint for a complete response. 
These patients were included in the ‘complete response’ and ‘good response’ groups for the 
two respective outcomes. 
Table 1 MR acquisition protocols
AP: Anterior-Posterior, LR: Left-Right, NSA: Number of Signals Averaged, EPI: Echo Planar Imaging, STIR: Short TI Inversion 
Recovery, SPIR: Spectral Presaturation Inversion Recovery, SPAIR: Spectral Attenuated Inversion Recovery
Table 2 Likelihood score used by the two radiologists to predict the 
chance of achieving a good or complete response, respectively, based 
on visual evaluation of the baseline MRI
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Visual morphologic assessment by expert radiologists
Two independent board-certified abdominal radiologists (DMJL and MJL), with each > 10 years’ 
specific experience in reading rectal MRI, estimated the likelihood of whether a patient would 
achieve a complete response (outcome 1) or good response (outcome 2), respectively, using a 
5-point subjective confidence score (1 = chance to achieve a complete/good response highly 
unlikely, 2 = good/complete response unlikely, 3 = equivocal, 4 = complete/good response 
likely, 5 = complete/good response highly likely). The readers based their score on their overall 
visual morphologic assessment of the size, signal and shape of the tumor, T- and N-stage, 
circumferential resection margin (CRM) and EMVI, according to the criteria described in Table 2. 
Tumors with more unfavorable characteristics (e.g., larger size, higher T-stage, positive N-stage, 
CRM+, EMVI+) were assigned lower scores. Readers were blinded for the patient’s outcome and 
each other’s results.
Figure 1. Study Workflow. Study workflow describing the image segmentation, registration and radiomic feature 
extraction steps (A) and data analysis steps (B). (A) Tumors were segmented on DWI-b1000. After co-registration of T2W and 
DWI-b0 images, segmentations were transformed for extraction from T2W images using the transformation map from the 
registration. Images and segmentation maps were then fed into the PyRadiomics pipeline (PyR) for feature extraction. 
(B) After exclusion of unstable features (1), data were divided in to training and validation sets by center, with center 1 used 
for training and 2 for validation (2). Feature values were normalized using mean and standard deviation of features in center 1 
(3). Using the training set and 5-fold stratified cross-validation, optimal hyperparameters were determined for the radiomics 
model. The optimized model was then trained on the full training set for each reader and each outcome separately. 
Finally, performance to predict response was assess in the training and validation sets (4). ICC: Intraclass Correlation 
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Radiomics workflow
The Radiomics feature extraction workflow, including image segmentation and radiomic 
feature extraction as the two main steps, is schematically illustrated in Figure 1A.
I – Image segmentation
The image segmentation comprises the first 3 steps of the workflow:
Step 1: Semi-automatic segmentation
Tumor volumes were semi-automatically segmented on the high b-value diffusion-images 
using a region-growing algorithm implemented in MANGO (Multi-image Analysis GUI, version 
3.8, Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX), 
according to methods previously reported22. The high b-value images were chosen as they 
provide a good tumor-to-background signal ratio. 
Step 2: Manual adjustment
The tumor segmentations derived in step 1 were then checked and manually adjusted where 
deemed necessary by four independent readers (two resident level non-expert readers 
(JJMVG and ST) and two expert radiologists (DMJL and MJL)) to allow assessment of effects 
of interobserver variations and reader experience level (see Figure 2). This resulted in a total 
of 5 segmentations (1 semi-automated, 2 non-expert, 2 expert) used for radiomic feature 
extraction. Overlap between segmentations was assessed using the dice similarity coefficient. 
Step 3: Registration of different imaging sequences
To correct for organ displacements and deformations, T2W and DWI images were co-registered 
using deformable B-spline registration implemented in Elastix23,24. The resulting deformation 
maps were then used to adapt the DWI-based segmentations to the T2W images.
II - Radiomic feature extraction
Feature extraction was performed using the PyRadiomics toolbox (version 2.1.2)25. Prior to 
feature extraction, images were normalized to 0 mean and 100 standard deviation to reduce 
influence of differences in MR system vendor and acquisition protocol between the two 
centers26 and subsequently interpolated to isotropic voxels with 2mm sides using a B Spline 
interpolator. To remove outlier intensity values, the five segmentations were re-segmented by 
excluding voxels which differed > 3σ from the mean. Prior to extraction of texture features and 
first order Uniformity and Entropy, gray values were discretized using a fixed bin width of 5. 
For each sequence (T2W, DWIb0, DWIb1000/11000, ADC), 623 intensity and texture features were 
extracted from non-derived, gradient, exponent, logarithm and Laplacian of Gaussian (σ ϵ {1mm, 
3mm, 5mm}) filtered images (yielding 4x623=2492 features). In addition, 13 shape descriptors 
were extracted from non-resegmented DWI-based segmentations, resulting in a grand total of 
2505 (2492 + 13) features for each of the five respective segmentations (1 semi-automated, 
2 non-expert readers and 2 expert readers). The PyRadiomics configuration file used is 
































































































































































































































































































































Statistical analysis was performed using the Python (v3.5.3) package Scikit-learn (v0.20)27 and is 
schematically illustrated in Figure 1B. Data from center 1 (n=86) were used for training, 
data from center 2 (n=47) were used for validation. Baseline characteristics were analyzed 
using χ2-test for categorical variables and independent samples t-test for continuous variables. 
Stability of radiomic features for inter-reader variation was assessed using intra-class 
correlation coefficient (ICC) and stability for differences in MR system vendor and acquisition 
protocol between the 2 centers was assessed using the Kruskal-Wallis (KW) test. Only features 
exhibiting sufficient stability (ICC ≥ 0.75 and KW p-value ≥ 0.05) were eligible for selection in 
the Radiomics prediction model. Stable features were normalized by subtracting the mean and 
dividing by the standard deviation on a per-reader basis. Mean and standard deviation for each 
feature is determined using only data from center 1 (training set).
Using the training set, the Radiomics model was trained separately for each of the 5 
segmentations in 2 steps: 1) Using minimum Redundancy Maximum Relevance (mRMR), 
implemented in Python package ‘mifs’28, a set of candidate features was selected from the 
training set, which 2) were fitted into a logistic regression model with L2 regularization and 
balanced class weights. To approximate the mutual information between the outcome and 
continuous features during mRMR selection, we employed the nearest neighbor method 
as described by Ross et al.29 Optimum number of features to select [5–10], as well as the k 
neighbors parameter [5–8] in mRMR and the C regularization parameter [10-7–102] in the logistic 
regression model were determined by 5-fold stratified cross-validation on the training set. 
Finally, the performance of the Radiomics model to predict a ‘complete’ and ‘good’ response, 
respectively, was assessed using the Wilcoxon rank-sum test and by calculating the area under 
the ROC-curve (AUC). Using the DeLong method30, AUC for Radiomics was then compared to 
the AUC calculated for the morphologic prediction of response by the two expert radiologists 
based on their subjective confidence scores. p-values < 0.05 were considered significant. 




TME Total Mesorectal Excision, W&W Watch & Wait (Organ saving treatment), TEM Transanal Endoscopic Microsurgery, 
cT, cN: clinical T and N stage as assessed on primary MRI, yT, yN: final T and N stage after nCRT as assessed at histopathology 
after surgery (n=120) or by long-term follow-up in case of wait-and-see treatment (n=13), TRG: Tumor Regression Grade, 
* t-test, † χ2 test
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The baseline characteristics of the patients are shown in Table 3. No significant differences 
were seen between the two centers. In total 28 patients were complete responders (15 after 
surgery and 13 sustained clinical complete responders undergoing W&S) and 105 patients had 
residual tumor. For the second clinical outcome, good versus poor response, 62 patients were 
considered good responders (28 TRG1, 34 TRG2) and 67 poor responders (38 TRG3, 25 TRG4, 
4 TRG5). In 4 patients (3 from center 1, 1 from center 2) no TRG stage was available; 
these patients were therefore excluded from the latter analysis. 
Figure 3. ROC-curves of morphologic assessment by radiologists and radiomics models to predict the outcome 
‘complete’ (A) and ‘good’ (B) response. There were no statistically significant differences in diagnostic performance between 
the 2 radiologist readers and the various radiomics models.
Performance of radiologists’ visual morphologic assessment to 
predict response
Results for the prediction of response by the two radiologists (compared to the performance 
of the radiomics models) are provided in Table 4 and illustrated in Figure 3. Overall, AUC to 
predict a complete response in the validation cohort was 0.83 for the first reader and 0.74 for 
the second reader. For the prediction of a good response, AUC was 0.68 (reader 1) and 0.67 
(reader 2) in the validation cohort. Agreement between the two readers was good with κ=0.64 
and κ=0.61 for the prediction of complete and good response, respectively. 
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Building the radiomics models
1692 out of the in total 2505 radiomic features (68%) showed an ICC ≥ 0.75 (indicating sufficient 
inter-reader stability), of which only 415 (25%) showed no confounding related to the MR 
system and acquisition protocol used (i.e. MRI performed in center 1 or center 2). These 415 
features were considered stable and available for selection by the radiomics model. 
Optimum settings for the model, as determined by the hyper-optimization in the training 
set, turned out to be 9 features, k=8 neighbors and C=10-5. Most emphasis was placed on 
DWI and ADC sequences, with only few features selected from T2W sequences in 8/10 
developed models. Further details regarding the selected features per model are provided in 
Supplementary materials 2.
Table 4 Performance to predict response
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Performance of the radiomics models to predict response
In the training set, radiomics models based upon manually-corrected segmentations showed 
significant performance to predict both ‘complete response’ (AUC 0.71 to 0.74) and ‘good 
response’ (AUC 0.69 to 0.77). In the validation dataset, AUCS ranged between 0.69 and 
0.79 (p=0.001-0.028) to predict a good response, with comparable performance for the 
segmentations performed by the two non-expert and expert readers. For the prediction of 
complete response, only the radiomics model using the segmentations from 1 expert and 1 non-
expert reader retained significant performance, with respective AUCs of 0.77 (p-value 0.010) 
and 0.73 (p-value 0.029). Performance of the radiomics model using the semi-automated 
segmentations (without manual reader input) was non-significant for both study outcomes. 
Average dice coefficients between the semi-automated and different non-expert and expert 
manual-input segmentations are shown in Table 5. 
Comparison between radiomics model and morphologic assessment by 
radiologists
AUCs for the radiomics models (using segmentations with manual input) were comparable 
to the AUCs for the visual morphologic assessment by the expert radiologists, both for the 
prediction of a complete response (0.73-0.77 versus AUC 0.74-0.83, P=0.25-0.88), as well as 
for the prediction of a good response (AUC 0.69-0.79 versus AUC 0.67-0.68 , P=0.18-0.93).




In the present study, we compared the performance of advanced radiomics analysis to visual 
morphologic assessment by experienced radiologists to predict response to neoadjuvant 
chemoradiotherapy on primary staging MRI. Results show that the radiomics model could 
predict a good response to therapy upfront with similar diagnostic performance (AUC 0.69-
0.79) as highly expert radiologists (AUC 0.67-0.68). Interestingly, the Radiomics models were 
mainly based on features derived from DWI and ADC, with only few features selected from T2W 
imaging. This would suggest that DWI plays an important role when building response prediction 
models based on Radiomics. Moreover, results of the radiomics model were comparable 
regardless of whether image segmentation was manually adapted by non-expert (young resident 
level) readers or by experienced radiologists, indicating that expert input is not required in 
order for the radiomics workflow to produce significant predictive performance. Radiomics 
models without manual input (using only semi-automated tumor segmentations) did not result 
in significant predictive performance, despite the fact that the spatial overlap between the 
semi-automated and manual-input segmentations was quite substantial (Dice 0.64-0.78).
Although in recent years several groups have investigated the potential of Radiomics for rectal 
tumor response assessment, our current report is one of few to compare Radiomics results 
to visual radiological assessment in order to put things into a more clinical perspective. To the 
best of our knowledge, only one previous report by Horvath et al.31 compared performance of 
Radiomics to expert reader assessment, though this study focused on response assessment 
after completion of therapy, rather than prediction upfront. In this study 34 features were 
extracted from 114 patients, and combined using a random forest classifier. This model showed 
excellent performance (AUC 0.93) in repeated cross-validation, which was significantly better 
than consensus scoring by 2 radiologists. A handful of previous studies specifically focused 
on MR-based Radiomics to predict rectal tumor response prior to the start of treatment 
using baseline imaging data. Nie K. et al32 extracted 103 features from primary T1/T2, DWI 
and dynamic contrast enhanced MRI in 48 patients. Here, an artificial neural network was 
trained using 4-fold cross validation to address overfitting, with resulting AUCs of 0.84 and 
0.89 to predict a complete and good response, respectively. Cusumano D. et al20 performed 
a similar study but included an independent validation data cohort from another center. 
Here, a combination of shape, fractal and LoG-based features were assessed in a cohort of 
198 patients, resulting in AUC 0.77 and 0.79 in the training and validation dataset, respectively. 
Finally, Cui Y. et al19 assessed performance of radiomic features in 186 patients, achieving a very 
high AUC of 0.98 in the validation set. However, feature stability for image acquisition variation 
was not assessed, which may limit clinical applicability. In our current bi-institutional study 
we used a test and validation dataset from two independent centers in order to investigate 
potential confounding effects of variations in MR system vendor and acquisition protocols. 
We found that a large portion (75%) of features were classified as unstable to variations in 
vendor and image acquisition protocols. This highlights the need for standardized protocols 
and the importance of assessing feature stability when developing radiomics models. On the 
other hand, despite these vendor and protocol variations, the radiomics models still achieved 
performance comparable to expert-reader assessment. 
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Although, the AUCs of 0.66–0.79 achieved in our current study to predict response are 
encouraging, they will probably not yet be considered good enough for clinical decision making. 
As discussed above there is however still room for improvement. Further research should focus 
on standardization, but also on combining radiomic features with for example other clinical, 
histopathological, immunohistochemical or genetic biomarkers, which is likely to increase the 
predictive power, as has also been suggested by previous research33,34. An accurate prediction 
of treatment response upfront, using biomarkers that can already be derived at baseline could 
impact clinical management in rectal cancer in the future. After completion of CRT, complete 
responders may already be accurately detected using a combination of simple visual DWI-
MRI analysis and endoscopy, which limits the need for advanced imaging analysis tools such 
as Radiomics in this setting35. Tools to predict treatment effects upfront are however not 
yet available in clinical practice. In locally advanced tumors, where downsizing is desired, but 
standard CRT is predicted to have little or no effect, one could consider a more intensified 
regimen or one that relies more on systemic therapy. If lateral resection margins are wide on 
MRI, one can even consider omitting neoadjuvant therapy altogether, avoiding unnecessary 
toxicity. In smaller rectal tumors, which are traditionally treated with TME surgery without 
neoadjuvant therapy, but which also have a higher chance to respond well to radiotherapy, 
a predictive model can guide treatment decisions towards (chemo)radiotherapy for the 
predicted responders with the goal to achieve organ preservation.
Our study design contained some limitations. The 95% confidence intervals for the 
performance of the radiological assessments as well as the radiomics models were large, most 
likely due to the relatively small size of the dataset, especially the validation set. Moreover, this 
small size of the training set can make the radiomics models prone to overfitting, as reflected 
by the fact that the optimum hyperparameters, with a low value for the C parameter and high 
value for the k parameter, favoring high regularization. Our result will therefore need to be 
further validated in larger and preferably multicenter cohorts to obtain more stable results. 
Additionally, the estimated likelihood of achieving a good/complete response by the radiologists 
remains relatively subjective (despite the criteria provided in Table 2) and is dependent on 
the experience level of the two readers. We chose this approach to provide some preliminary 
perspective on how advanced model-based prediction methods would compare to what can 
potentially be achieved by mere “human” interpretation. We, however, acknowledge that an 
alternative approach including separate assessment of individual semantic features may allow 
for better reproducibility. This is a strategy we aim to further explore in future research. 
Finally, the analyses were all performed in patients with locally advanced rectal tumors. 
Our results will also need to be tested and validated in smaller tumors before radiomics models 
can be applied in these cases.
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In conclusion, we were able to train radiomics models to reach comparable performance to 
predict response to chemoradiotherapy on baseline MRI as visual morphologic assessment 
and staging by highly expert radiologists, even when using tumor segmentations without any 
expert radiologist input. Furthermore, these results were obtained despite training on a very 
heterogeneous dataset, where the majority of features had to be excluded due to susceptibility 
for variations in image acquisition. Although validation in a large multicenter cohort is obviously 
needed, these results indicate that Radiomics has strong potential to identify meaningful 
imaging biomarkers that can be included in clinically usable prediction models with the ultimate 
aim to further optimize and personalize treatment in rectal cancer.
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Using high-throughput radiomics, quantitative information can be extracted from medical 
imaging that can be used to generate a comprehensive oncologic imaging fingerprint, 
thereby rendering many potential novel imaging biomarkers of disease. These biomarkers may 
aid in addressing clinical challenges in oncology through the development of predictive models, 
which may ultimately be combined with other clinical, histopathological, immunohistochemical 
and genetic markers to build strong clinical decision-support tools with impact on oncologic 
treatment management and outcome. Before achieving this ultimate “horizon” goal, there are 
several more “proximate” goals that will need to be accomplished first. This thesis focuses on 
the latter and addresses specific challenges in each step of the radiomics workflow that need 
to be overcome to facilitate high-quality research and ultimately pave the way for application of 
radiomics in clinical practice. 
Addressing the challenge of image segmentation with AI 
Before a computer is able to extract radiomics features from medical images, it needs to 
know what is the region of interest (ROI) within the image. This ROI – which in oncological 
imaging often entails the tumor lesion under investigation – is typically defined by means of 
“segmentation”, in other words by tracing the boundaries of the tumor lesion within the image. 
Several previous studies have shown that precise delineation of the whole tumor volume 
by means of manual segmentation provides the most reproducible results as compared to 
“simpler” methods such as selecting a single representative slice or sample measurement 
within the tumor1–3. The main drawback of manual whole-volume segmentation is that it can 
be very labor intensive and time consuming (especially in large-size lesions) and that significant 
inter-reader variation may occur, especially when segmentations are performed by readers 
who are less experienced in radiological image interpretation4. This dependence on (expert) 
segmentation input severely hampers the feasibility of implementing radiomics algorithms in 
daily practice. In 2015 our group took the first steps to addressing this problem and attempted 
a fairly simple segmentation algorithm to support radiologists in semi-automatically segmenting 
rectal tumors on MRI. Though this already led to a significant reduction in the time required for 
segmentation, results were far from optimal and significant correction was required in multiple 
cases4. In this thesis, we expanded our research on tumor segmentation and set out to develop 
and train a deep learning network to provide fully-automatic segmentation of rectal tumors on 
MRI aiming to minimize the input required from radiologists to an absolute minimum. 
In our pilot study in Chapter 2 we used a simple patch-based convolutional network (CNN) and 
applied it to a multiparametric image dataset consisting of T2-weighted, high and low b-value 
diffusion-weighted images, to make optimum use of the high tumor-to-background ratio found 
in DWI combined with the better visualization of anatomical detail on T2W-MRI. This network 
predicted pixel-by-pixel which area in the image represented the rectal tumor, based on 2D 
patches extracted around each pixel. When comparing network-inferred segmentations to 
manual segmentations generated by an expert-radiologist using dice similarity scores (DSC) – 
a measure to indicate the spatial overlap between two segmentations on a scale from 0 to 1– 
results were promising with an overall DSC 0.70. Main limitations of the algorithm from Chapter 
2 were its relatively slow pixel-by-pixel inference (meaning that each voxel was independently 
classified, based on the extracted image patch surrounding the voxel) and the fact that the 
small patch size resulted in limited spatial context with incorrect classification of structures 
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near the edges of the images. Also, the algorithm was trained and tested using data from 
only two centers, while ideally an AI model should be subjected to heterogeneous data from 
multiple institutions to generate a model that will be broadly applicable to any clinical dataset. In 
Chapter 3, we addressed these limitations and further optimized our segmentation algorithm by 
using an attention-gated U-Net, which only requires one forward pass for inference, 
and has greater spatial context, especially due to the addition of attention-gating. We trained 
and tested this model in a heterogeneous dataset with rectal MRIs from 6 different centers. 
In addition, we investigated the influence of DWI scan quality and tumor complexity on the 
networks’ performance. We learned that reduced DWI scan quality negatively impacted the 
networks’ performance, again stressing the importance of optimizing acquisition protocols and 
taking steps to avoid artefacts as addressed in Chapter 4 and discussed below. 
Network performance for segmentation was also reduced in highly complex (i.e. irregularly 
shaped and heterogeneous signal) tumors, similar to how inter-reader agreement was also 
lower in these complex cases. All in all, we found that for the majority of more “straightforward” 
tumors, the network could achieve a performance that was almost similar to the agreement 
between two expert radiologists, provided that image quality was good. In these cases, AI could 
really offer a solution to reduce the workload of image segmentation in the radiomics workflow. 
In the future, the necessity of accurate image segmentation as a requirement for analysis may 
change as deep learning techniques offer the potential to train models to directly predict the 
outcome (e.g. response to treatment) from the acquired images, without the need for carefully 
handcrafted features or image segmentation. In rectal cancer, a few preliminary studies have 
shown encouraging results for such an approach5,6, though future studies are needed to 
compare these new methods to the ‘classic’ radiomics approach using a predefined ROI and 
handcrafted features. 
Addressing the challenge of image quality: 
DWI susceptibility artefacts
Diffusion-weighted imaging (DWI) is one of the most commonly used functional MR imaging 
sequences in oncology. In highly cellular malignant tumors, the movement or “diffusion” of 
water molecules is restricted and a high signal is retained, whereas in low-cellular tissues, the 
signal exponentially decreases. This makes high-cellular tumors stand out compared to their 
background, making DWI a prime candidate for the detection of tumor and the development of 
(semi-)automated tumor segmentation algorithms4. For rectal cancer many centers now include 
DWI in their MRI protocol, especially in the restaging setting where current clinical guidelines 
advise the use of DWI because of its superiority to standard MRI in distinguishing residual tumor 
from post-radiation fibrosis10–12. The diffusion characteristics of tissues can also be quantified, 
most commonly expressed as the apparent diffusion coefficient or “ADC”. Several studies 
in rectal cancer as well as other tumor types have shown that ADC as a measure of tumor 
cellularity has potential as a biomarker for tumor aggressiveness7, response8, 
and survival9. 
An important potential drawback of DWI is that it can be quite challenging to acquire DW 
images with consistently good quality, that is reliable enough for clinical interpretation as well 
as for further image analysis. DWI sequences are generally acquired using echo planar imaging 
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(EPI) sequences, which allow fast image acquisition but are relatively prone to susceptibility 
artifacts15. Susceptibility artefacts cause a local signal change or distortion due to local 
magnetic field inhomogeneities. In bowel imaging, these inhomogeneities are often caused 
by intraluminal gas and the resulting artefacts may seriously hamper the quality of DWI exams 
of the rectum. In published reports on bowel DWI, up to 11% of cases were excluded due to 
insufficient quality of the DWI images16–19. In our study in Chapter 4 we found that without 
additional preparation, 24% of the scans contained clinically relevant susceptibility artefacts. 
To reduce these artefacts there are basically two options: either to change the acquisition 
parameters (making the scan more robust to the effects causing the artefacts) or alternatively 
to reduce or remove the cause of the artefacts. This latter approach was investigated in 
Chapter 4, where we employed a preparatory micro-enema that can be self-administered by 
patients shortly prior to MR acquisition to reduce the intestinal gas causing the susceptibility 
artefacts on DWI. We found that this relatively simple intervention resulted in a marked 
reduction of both the incidence and severity of artefacts, with less than 4% of scans showing 
clinically relevant artefacts after preparation with the micro-enema, making it a very effective 
approach to optimize image quality in rectal DWI.
Towards easy and reproducible radiomics feature 
extraction: PyRadiomics
The features that are typically extracted in a radiomics study can be subdivided into 3 main 
groups. The first group is the “simple”, first-order features, which describe the general 
distribution of gray values in the ROI, regardless of their spatial location. These features can 
generally be derived directly from the statistical gray value histogram. The second group is the 
shape features that describe the 2D or 3D shape of the ROI, including parameters such as the 
volume, surface area and maximum diameters. This type of features makes no use of the gray 
values encountered in the ROI, but rather the spatial locations of the segmented voxels. The 
final group of features, generally referred to as second or higher order features, are texture 
features that describe the relationship of the gray values and their spatial relationship to one 
another, thereby highlighting the heterogeneity of the texture within in the ROI13. Finally, Aerts 
et al.7 defined a 4th group, containing histogram and texture features which have been extracted 
from the image after applying a filter highlighting certain aspects of the image, such as wavelet 
and Laplacian-of-Gaussian filters. In addition, several pre-processing steps may be undertaken 
to improve the reproducibility of the extracted features, such as clustering pixels according to 
intensity values (“discretization”), geometric resampling to obtain volumes with identical pixel 
spacing, or gray value normalization to obtain images with comparable ranges of intensity values.
Though many of the principles (i.e. mathematical algorithms) behind radiomic features have 
long since been described in multiple publications20–22, the process to extract these features 
from medical images – including pre-processing steps to prepare the images for data extraction 
– has lacked standardization prior to the start of this thesis23–26. Many published reports on 
radiomics used in-house developed software for feature extracting, which severely hampers 
the reproducibility and comparability of the reported results. In Chapter 5 we introduced 
PyRadiomics, an open-source python package developed specifically to address this challenge 
and provide a transparent, standardized and reproducible tool for radiomics feature extraction. 
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It was developed with heavy emphasis on ease-of-use and readability of the source code. 
Special care was taken to provide extensive documentation on both the underlying principles 
of the radiomics feature extraction process, as well as the specific implementation provided 
in PyRadiomics. To aid researchers without programming experience in performing radiomics 
analyses, a graphic user interface was provided in the form of SlicerRadiomics, 
an extension module for the medical image analysis software 3D Slicer. Since its publication in 
2017, PyRadiomics has become a popular package and reference tool for feature extraction 
in radiomics research with publications of its use in various cancer types27–33 and applied to 
multiple imaging modalities, including MRI27–30, CT31,32, PET30 and ultrasound33. Though mainly 
used for research in oncologic imaging, it has also been applied in non-oncologic34 and even 
non-medical imaging35. 
Putting it to the test: application of radiomics in rectal cancer
In Chapter 6 we put radiomics, using the PyRadiomics software developed in Chapter 5, 
to the test in a clinical study aiming to predict therapeutic response in rectal cancer. 
Predicting response to neoadjuvant treatment is one of the main current clinical challenges 
in rectal cancer, owing to the recent introduction of organ-preserving treatment strategies 
such as the “watch-and-wait” policy for patients that show a complete regression of their 
rectal tumor after neoadjuvant chemoradiotherapy (CRT). Identifying those patients who have 
obtained a complete response after CRT is essential to select the right patients to be treated 
with a watch-and-wait. In addition, pre-treatment prediction of response could aid in further 
optimization and personalization of neoadjuvant treatment schemes to increase the chance of 
obtaining a complete response in the good responders and spare non-responders the exposure 
to unnecessary morbidity of “futile” CRT prior to major surgery. In Chapter 6 we developed a 
radiomics model to predict response upfront, i.e. before onset of treatment, using the input 
of primary staging MRIs. We compared the performance of this model to an approach where 
treatment response was predicted by 2 expert radiologists based on their visual assessment of 
the same images, to place the results in a more clinical context. 
Excitingly, we found that the radiomics model performed equally compared to these expert-
reader predictions, indicating great perspective for AI in developing support tools that can 
truly benefit clinical decision making in the future. These results are in line with various 
other reports that have meanwhile been published and similarly suggest a beneficial role for 
radiomics and AI in this clinical setting, as well as to predict other clinical outcomes such as risk 
of lymph-node metastasis36, distant metastasis37, and survival38. Referring to the importance 
of image segmentation addressed in Chapters 3 and 4, we again found that a sufficient level 
of segmentation accuracy was a requirement for the model to result in significant predictive 
performance. Moreover, we found that a significant portion of the features (~75%) was 
correlated to the acquisition system and had to be excluded from analysis. This highlights the 




Future perspectives and recommendations
Though promising, the results of the radiomics model in Chapter 6 are not yet good enough 
to influence clinical decisions. Apart from the fact that the model should be further optimized 
and validated using multicentric datasets, the data derived from radiomics should be combined 
with other clinical information and data. Current clinical management of cancer is not based 
on imaging alone, but based on multi-disciplinary evaluations incorporating information derived 
from clinical examinations, imaging, histopathology, and laboratory testing. Similarly, it makes 
sense that AI models that can offer sufficient power to aid in clinical decision making should 
also be based on input from several different fields. Future studies should therefore aim to 
develop comprehensive predictive models, incorporating information from imaging through 
radiomics, but also “semantic” features such as clinical TNM stage, as well as state of the art 
histopathologic and genetic biomarkers derived from biopsies and more novel techniques 
such as liquid biopsies. There have already been some interesting “radiogenomics” studies 
demonstrating that radiomics features can be directly correlated to genetic biomarkers39–41 
and may even be used to predict mutational status without the need for invasive biopsies.
The results of our clinical study in Chapter 6 were still largely based on manual segmentations, 
performed by human readers. Future research should expand on the use of automatic 
segmentation methods, such as the ones developed in Chapters 2 and 3, and investigate 
the performance of radiomics models where these automatically generated segmentations 
are incorporated as the main source of segmentation input with no or only minimal need for 
manual corrections. Such approaches are expected to significantly reduce the time required 
to complete the radiomics workflow and may significantly contribute to the implementation of 
radiomics in future trials and ultimately into clinical practice.
In addition, deep learning algorithms such as those used for the automatic segmentation of 
rectal tumors in Chapters 2 and 3 may also be of use in addressing other challenges. 
For example, deep learning could be used to aid in automatic assessment of image quality and 
in building workflows to reduce systematic differences between scans related to acquisition 
protocol and vendor variation. Moreover, deep learning networks may be trained to predict 
clinical outcomes (such as the likelihood of response) directly from the MRI sequences, without 
the need for segmentation or carefully handcrafted features.
Finally, there are those who postulate that AI will soon replace the radiologist in the process of 
image analysis, raising doubt amongst current medicine students whether it is still wise to date 
to pursue a future career in radiology. However, in my opinion AI will never replace but rather 
enhance the radiologist profession. As has previously been demonstrated in breast cancer 
detection, computer aided detection systems (“CAD” a form of AI already used in clinics) did 
not reduce the need for radiologist input, but instead greatly enhanced the clinical information 
a radiologist can provide. Therefore, AI will not supplant the radiologist, but the radiologist who 




In this thesis we have addressed the main challenges that arise in the radiomics workflow within 
the context of rectal cancer imaging as a clinical case example. We investigated the challenge 
of creating a dataset suitable for radiomics research, and found that application of a micro-
enema can significantly reduce the number and severity of gas-induced susceptibility artefacts 
on diffusion-weighted MR imaging. We have shown the potential of deep learning to aid in the 
labor-intensive task of tumor segmentation. Finally we have developed an open-source toolbox 
for easy and reproducible feature extraction that is now used by research groups worldwide 
thereby facilitating transparent radiomics research. Using this toolbox ourselves, we have shown 
the potential of radiomics to build imaging-based prediction models to predict response to 
neoadjuvant chemoradiotherapy in rectal cancer.
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Summary
There are several key steps in the radiomics workflow, each associated with their own 
challenges that need to be overcome on the road towards implementing artificial intelligence 
tools in the clinical workflow of radiology. The goal of this thesis is to investigate these key steps 
and challenges, using the application of radiomics in rectal cancer as a clinical example. 
Segmentation
Chapter 2 focuses on lesion segmentation, an important first step to allow extraction of 
quantitative features from a given tumor lesion on medical imaging. We investigated the 
potential of Deep Learning for fully-automated segmentation of rectal tumors on primary 
staging MRI, using a combination of T2-weighted imaging and Diffusion Weighted Imaging (DWI) 
sequences. This initial study used a fairly simple patch-based approach, where the network was 
trained to predict whether a voxel was part of the rectal tumor, based on a small surrounding 
region. By extracting and classifying patches for all voxels in the input image, a segmentation 
could be inferred. In the test set we achieved a high performance with Dice Similarity 
Coefficients (DSC; indicating the spatial overlap between two segmentations on a scale from 
0 to 1) between network and manual segmentations of 0.68-0.70, though performance was 
lower than the agreement between two radiologists performing manual segmentations (0.83 
DSC). Moreover, the patch-based approach was hampered by slower inference and low spatial 
awareness. This was also reflected by the results showing that the network struggled with larger 
Field-of-View (FOV) acquisitions, erroneously classifying structures near the edge of the FOV 
as tumor.
More advanced deep learning networks, such as the U-Net are able to process the entire image 
in a single inference, greatly increasing speed and spatial awareness. In Chapter 3, we optimized 
the network from Chapter 2 to address these limitations, using a U-Net with additional attention 
gating, which helps the network to focus on the area of interest. Furthermore, we explicitly 
investigated the influence of scan quality and tumor complexity on network performance 
and interreader agreement in a large multicenter dataset with a high variation of acquisition 
protocols and scan quality. Though performance of the AI model in the test set was still inferior 
to agreement between radiologists, with DSCs of 0.67 vs. 0.75, the difference was markedly 
smaller compared to the findings in Chapter 2. Tumor complexity had the largest influence on 
network performance, with more heterogeneous and irregular tumors resulting in lower DSC 
scores. Interestingly, tumor complexity had a similar negative effect on the agreement between 
two radiologists, indicating that these tumors are inherently difficult to segment for computers 
but also for experienced radiologists. The signal-to-noise on DWI also affected network 
performance, though to a lesser extent than tumor complexity.
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Image Quality
As also highlighted in Chapter 3, image quality is an important prerequisite for Radiomics and 
AI research. In Chapter 4, we addressed this challenge focusing specifically on the acquisition 
of DWI of the rectum. Rectal DWI can suffer from significant artefacts caused by the presence 
of intraluminal gas in the rectum which can have a severe negative impact on diagnostic 
evaluations. We investigated the application of a preparatory micro-enema shortly prior to 
acquisition to reduce the amount of intraluminal gas. We observed a marked reduction of 
significant artefacts from 24% in scans acquired without a micro-enema to <4% in scans 
performed after application of the micro-enema, showing that even a fairly simple intervention 
may significantly improve DWI scan quality.
Feature extraction and modelling
In Chapter 5, we addressed the challenge of reproducibility in feature extraction. To this end, 
we developed PyRadiomics, an easy-to-use open source package for radiomics feature 
extraction. It is developed in Python, a popular programming language used by many 
researchers investigating the application of radiomics in medical imaging, coupled with 
extensions in C for high-performance feature extraction. 
Finally, in Chapter 6, we put the radiomics workflow to the test, investigating the application of 
radiomics to predict the response to neoadjuvant chemoradiotherapy in rectal cancer patients, 
using only the pre-therapy staging MRI. We compared the performance of a radiomics-based 
prediction model to the performance of expert radiologists who predicted the response to 
chemoradiotherapy based on their visual interpretation of the images. The radiomics models 
achieved a promising performance, with AUCs of 0.69-0.79, which were comparable to the 
performance of the visual predictions by the expert radiologists. The radiomics model was built 
using different types of tumor segmentation, performed manually by either expert radiologists 
or non-expert readers, but also semi-automatically using a basic segmentation algorithm. 
Interestingly, radiomics performance was similar when using the expert or non-expert manual 
segmentations, but significantly poorer when using the semi-automatic segmentation algorithm. 
This highlights the need for better automatic segmentation support tools, such as those 
addressed in Chapters 2 and 3. 
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Samenvatting
In het proces van radiomics zijn enkele belangrijke stappen te onderscheiden, elk geassocieerd 
met uitdagingen die moeten worden overwonnen op de weg naar klinische implementatie 
van kunstmatige intelligentie (ook wel “artificiële intelligentie”of “AI”) in de dagelijkse praktijk 
van de radiologie. Het doel van deze thesis is het onderzoeken van deze stappen en de 
bijbehordende uitdagingen, gebruik makende van de toepassing van kunstmatige intelligentie bij 
endeldarmkanker als klinisch voorbeeld.
Segmentatie
Om kwantitatieve analyse van bijvoorbeeld een tumor laesie mogelijk te maken, is segmentatie van 
de betreffende laesie op beeldvorming een eerste belangrijke noodzakelijke stap. In Hoofdstuk 
2 werd de potentie van AI (Deep Learning) voor het volledig geautomatiseerd segmenteren van 
tumoren in de endeldarm onderzocht. Hiervoor werd gebruik gemaakt van een combinatie van 
T2-gewogen en diffusie gewogen imaging (DWI) sequenties die beide onderdeel uit maken het 
standaard MRI protocol voor endeldarmkanker. In deze initiële studie werd gebruik gemaakt van 
een vrij eenvoudig netwerk, waarbij per voxel binnen het MRI plaatje werd voorspeld of deze 
wel of niet tot het tumorgebied behoorde op basis van analyse van een kleine omliggende regio. 
Een volledige segmentatie van de tumor werd op deze manier verkregen door dit proces te 
herhalen voor elke voxel in de MRI scan. Toepassing van dit netwerk op een onafhankelijke test 
set toonde een goed resultaat, met een Dice Similarity Coefficient (DSC; een maat om de spatiele 
overlap tussen 2 segmentaties weer te geven op een schaal van 0 tot 1) tussen het AI-model en 
manuele segmentatie door een radioloog van 0.68-0.70. Dit resultaat was echter nog niet geheel 
vergelijkbaar met de overeenstemming tussen manueel verkregen segmentaties van twee ervaren 
radiologen (DSC 0.83). Bovendien werd het netwerk gelimiteerd door de regio-gebaseerde 
methode, wat leidde tot trage segmentatie en weinig ruimtelijk inzicht. Deze nadelen zijn ook 
herkenbaar in de resultaten, waarbij het netwerk bij beelden met een groter afgebeeld gebied 
(Field-Of-View, FOV) foutief structuren aan de rand van de afbeeldingen classificeerde 
als “tumor”.
Meer geavanceerde Deep Learning AI netwerken, zoals het U-Net, zijn in staat een afbeelding 
in zijn geheel te verwerken en zijn zodoende in staat meer ruimtelijk inzicht te tonen. Om de 
limitaties van het netwerk uit Hoofdstuk 2 te overkomen hebben wij dan ook gebruik gemaakt 
van een dergelijk U-Net in Hoofdstuk 3, met de toevoeging van “attention-gating” bedoeld om 
het netwerk te helpen focussen op het belangrijkste doelgebied binnen de scan: de endeldarm 
en het omliggende vetweefsel. Naast een meer geavanceerde architectuur van het netwerk 
hebben we ook expliciet de invloed van beeldkwaliteit en tumor complexiteit op de accuratesse 
van de segmentaties onderzocht. Hoewel de accuratesse van het netwerk ook in dit onderzoek 
lager uitviel in vergelijking met de overeenkomst tussen ervaren radiologen onderling (DSC 0.67 
versus 0.75), was het verschil duidelijk kleiner dan in Hoofdstuk 2. Tumor complexiteit had de 
grootste invloed op de segmentatie accuratesse, waarbij meer heterogene en grillig gevormde 
tumoren zowel voor het AI netwerk als voor de radiologen resulteerden in lagere DSCs. Dit leert 
ons dat deze meer complexe tumoren inherent lastiger zijn om te segmenteren. De beedlkwaliteit 
(signaal-ruis verhouding) van de DWI-beelden was ook van invloed op de accuratesse van het 
netwerk, al was dit effect minder uitgesproken in vergelijking met de tumor complexiteit.
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Beeldkwaliteit
Zoals ook beschreven in Hoofdstuk 3, is goede beeldkwaliteit een belangrijke vereiste voor 
onderzoek op het gebied van Radiomics en kunstmatige intelligentie. In Hoofdstuk 4 hebben 
we deze uitdaging onderzocht in het specifieke geval van beeldartefacten op DWI sequenties 
van de endeldarm. Bij deze beelden kunnen ernstige susceptibiliteitsartefacten optreden die 
worden veroorzaakt door de aanwezigheid van lucht in de endeldarm, welke kunnen leiden 
tot substantieel verslechterde beoordeelbaarheid van deze beelden. In deze studie hebben 
wij onderzocht of het toepassen van een micro-klysma leidt tot een verminderde hoeveelheid 
intra-luminaal lucht en dus tot een afname in de aanwezigheid van artefacten. Wij hebben 
kunnen constateren dat deze toepassing inderdaad leidde tot een duidelijke vermindering 
van klinisch significante artefacten, met een reductie tot <4% na toediening van het micro-
klysma versus 24% in scans vervaardigd zonder micro-klysma. Dit toont aan dat zelfs een vrij 
eenvoudige interventie kan leiden tot een significante verbetering van beeldkwaliteit.
Feature extractie en data modellering
Om de reproduceerbaarheid van radiomics-onderzoek te vergroten hebben wij een open-
source software pakket ontwikkeld, genaamd PyRadiomics. In Hoofdstuk 5 introduceren wij 
dit pakket. Het is ontwikkeld in Python, een populaire programmeertaal bij onderzoekers in 
het veld van medische beeldvorming. Bovendien is het specifiek ontwikkeld met het oog op 
het gebruik door een gemeenschap van radiomics-onderzoekers, met extra nadruk op de 
leesbaarheid van de broncode en uitgebreide documentatie. Om een hoge doorvoersnelheid 
van de feature extractie te garanderen, zijn enkele stukken van het pakket in 
C-code geschreven.
Tot slot hebben we het proces van radiomics getest in Hoofdstuk 6 in een klinische studie naar 
endeldarmkanker, waarbij we de applicatie van radiomics voor het voorspellen van respons op 
neoadjuvante chemoradiotherapie hebben onderzocht met behulp van MRI scans vervaardigd 
voor start van de behandeling. We hebben de accuratesse van een radiomics-model vergeleken 
met de accuratesse van ervaren radiologen, welke hun voorspelling baseerden op een visuele 
interpretatie van dezelfde beelden. Het radiomics model toonde een veelbelovend resultaat 
met een AUC van 0.69-0.79, vergelijkbaar met de accuratesse van de ervaren radiologen. 
Het radiomics-model werd ontwikkeld met behulp van segmentaties die manueel werden 
vervaardigd door respectievelijk ervaren radiologen en meer onervaren lezers, maar ook een 
door een simpel semi-automatisch segmentatie algoritme. Hieruit bleek dat het radiomics-
model een goed en vergelijkbaar resultaat gaf ongeacht het ervarings niveau van de handmatige 
intekeningen, maar duidelijk slechter presteerde wanneer het semi-automatische algoritme 
werd gebruikt. Dit benadrukt de noodzaak voor het ontwikkelen van betere segmentatie 
algoritmen zoals die onderzocht werden in Hoofdstukken 2 en 3.
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Main aims and outcomes of this thesis
Medical imaging, such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and 
Positron Emission Tomography (PET), helps doctors to detect, stage and monitor tumors, 
which provides them with information that is crucial to help define the best possible treatment 
for each individual cancer patient. In current clinical practice, medical images are mainly 
assessed “qualitatively”, meaning that the images are assessed visually by trained radiologists, 
who report their findings in text reports. There are however also several ways to assess medical 
images quantitatively. Some simple quantitative tools are already being used in daily clinical 
practice, including for example size or signal intensity measurements. In recent years, the 
possibilities of quantitative medical imaging analysis have evolved tremendously. An important 
development in this field has been the introduction of radiomics. In radiomics, the phenotype 
of a target volume within a medical image (e.g., a cancer lesion on a CT or MRI scan) is captured 
through extraction of a large panel of ”features”, calculated using advanced mathematical 
formulas. This allows for the extraction of much more information from the medical imaging 
than is visible by the ‘naked eye’1. Using artificial intelligence (machine learning) computer 
methods, this information can be correlated to various clinical outcomes such as the response 
of a tumor to anti-cancer treatment. This way, the radiomics phenotype can be used to render 
imaging-biomarkers of disease that can be incorporated into clinical prediction models, which 
may ultimately act as decision-support tools to aid in further personalization of treatment for 
cancer patients. 
In this thesis we addressed some of the key challenges in the radiomics workflow, using rectal 
cancer as a case example. Radiomics requires segmentation of the volume of interest within 
an image (e.g. a tumor lesion), which can be a very time consuming task requiring many hours 
of manual input from radiologists. The results in Chapters 2 and 3 show that fully-automatic 
segmentation of rectal tumors on MRI is feasible using artificial intelligence (AI) models, which 
can serve as a starting point and significantly reduce the amount of manual input required from 
radiologists. Another important prerequisite for successful radiomics analysis is the availability 
of good quality source images. Diffusion-weighted imaging (DWI) is nowadays an integral part 
of many oncologic MR imaging protocols and commonly used for quantitative MRI data analysis. 
In Chapter 4 we have shown that a simple intervention such as a preparatory micro-enema 
can help to greatly increase DWI scan quality. As shown in Chapter 3, this can contribute to 
improved performance of automatic segmentation protocols. A final challenge in the radiomics 
workflow is feature extraction, which is largely dependent on the mathematical formulas used 
and the implementation of these formulas in feature extraction software algorithms. 
In Chapter 5 we introduce PyRadiomics, an open-source toolkit for easy and reproducible 
feature extraction. It has been specifically developed for use in a community of radiomics 
researchers, aiming to increase the transparency and reproducibility of radiomics research 
by providing an easy go-to resource for feature extraction. In Chapter 6, we have put the 
radiomics workflow to the test in a clinical study and have shown that radiomics has potential to 
render valuable imaging biomarkers for pre-treatment prediction of response to neoadjuvant 
therapy in locally advanced rectal cancer. 
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Relevance
The results presented in this thesis may help future research in radiomics, paving the way on 
the road towards clinical implementation. The segmentation algorithms presented in Chapters 
2 and 3 aim to automate the segmentation step of the radiomics workflow. Especially when 
combined with optimized acquisition protocols, these algorithms can act as support tools to 
greatly improve the efficiency and reduce the workload of image segmentation. 
The PyRadiomics toolbox introduced in Chapter 5, with extensive documentation and publicly 
available source code, is aimed at widespread use by a global community of radiomics 
researchers. This removes the need for researchers to learn and implement radiomics features 
in custom-built code and contributes to increased reproducibility and comparability of 
published work. The success of PyRadiomics is reflected in its worldwide use – even serving as 
the radiomic feature extractor in several commercial products – and high number of citations 
for the paper2 introducing this toolbox. Finally, results in Chapter 6 show the potential of 
radiomics for rendering valuable predictive biomarkers in rectal cancer. In future research, 
these may be incorporated into clinical prediction models, ultimately aiming to improve patient-
tailored treatment planning and outcomes.
Target population
There are several groups who may benefit from the results presented in this thesis. The first 
are the researchers investigating the application of radiomics. Though this thesis is placed in 
the context of radiomics in rectal cancer, the workflow and challenges encountered – and the 
solutions offered in this thesis – can be generalized and applied to radiomics research in other 
oncological and non-oncological research fields.
Once properly validated in multicenter and prospective clinical studies, radiomics may aid 
healthcare professionals to build decision support models to better stratify patients, 
getting the right treatment to the right patient. However, before implementation into clinical 
workflows is feasible, the challenges described in the thesis need to be overcome.
Activities
The results presented in this thesis have been actively distributed, both through publication 
of results in peer-reviewed journals and presentation at multiple national and international 
conferences. The knowledge gained in this thesis is also currently being applied through new 
collaborations in follow-up research projects investigating radiomics and AI in rectal cancer 
as well as other tumor types. One such collaboration is an ongoing multicenter trial with 
participation of ten different centers in the Netherlands, including academic and oncology 
referral centers, but also several large teaching hospitals. This study aims to further build on the 
results acquired in chapter 6 by validating the predictive value of radiomics to predict rectal 
tumor response in a large multicenter dataset with large data heterogeneity, reflecting the 
regular clinical workflow. 
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The knowledge gained in this thesis is also incorporated into and distributed via the 
PyRadiomics platform. This is achieved through the public access and open-source nature of 
this toolbox, which is being used by a continuously growing community of researchers world-
wide. PyRadiomics is now also part of the “Imaging Biomarker Standardization Initiative” (IBSI)3, 
which aims at standardization of radiomic feature extraction, regardless of 
software implementations. 
Ultimately, biomarkers derived from medical imaging using radiomics and AI will most likely only 
be a part of the prediction. Like multidisciplinary tumor boards incorporating information from 
multiple aspects of healthcare, a combination of information derived from imaging as well as 
other clinical, histopathological and genetic sources will most likely result in higher performance 
than can be achieved with imaging data alone. To this end, collaboration between researchers 
of multiple disciplines is crucial to build the strongest possible clinical prediction models and 
decision-support tools that can really have an impact on patient management and ultimately 
treatment outcomes. 
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Het laatste – en mogelijk meest gelezen – hoofdstuk is het dankwoord. Zonder veel directe en 
indirecte hulp was dit werk er niet geweest. In dit hoofdstuk wil ik graag iedereen bedanken die 
hebben bijgedragen aan het tot stand komen van dit werk.
Allereerst wil ik graag mijn promotoren bedanken, prof. dr. Beets-Tan en prof. dr. Hugo Aerts. 
Beste Regina, het is nu bijna 6 jaar geleden dat je naar Amsterdam bent verhuisd en mij hebt 
gevraagd of ik mee wilde gaan als nieuwe PhD-student bij de afdeling radiologie van het Antoni 
van Leeuwenhoek ziekenhuis. Hierbij heb je me nog gewaarschuwd dat het wel een hele 
technische PhD zou worden, waarop ik vrij lacherig reageerde dat dat niet zo’n probleem zou 
zijn. Ik hoop dat mijn lacherige reactie in de laaste jaren begrijpelijk is geworden. Ik vond het 
een eer om onder jouw vleugels mijn onderzoek te mogen doen.
Beste Hugo, daar waar Regina de klinische kant van mijn PhD waarborgde met haar uitgebreide 
ervaring met beeldvorming bij endeldarm kanker, nam jij de technische kant van mijn PhD 
voor jouw rekening. Ik zal je altijd dankbaar blijven voor alle kansen die je mij hebt geboden, 
waardoor ik het gevoel heb dat ik echt een impact heb kunnen maken met ons onderzoek.
Doenja, mijn co-promotor. Ondanks dat je elke keer weer volhield dat je van al die technische 
dingen geen bal verstand had, was mijn promotie niet gelukt zonder jouw steun bij al het andere 
wat ik maar tegenkwam tijdens mijn promotie. Elke eerste revisie was voor zeker de helft rood 
gekleurd, al kwam dit wel steevast met een opmerking in de mail dat het wel een goed stuk was, 
en het meer “textuele” aanpassingen waren. 
Graag wil ik ook de leden van mijn beoordelingscommissie – bestaande uit prof. dr. Stassen, 
prof. dr. Lambin, prof. dr. Wildberger, prof. ir. Van Ooijen en dr. Visser – bedanken voor de tijd 
en moeite die ze hebben genomen om dit werk te beoordelen.
Elk artikel is een team-effort en ik wil dan ook alle co-auteurs bedanken voor hun waardevolle 
input en de moeite die ze hebben genomen om mee te denken, mee te schrijven en mee te 
onderzoeken naar radiomics en AI in rectal cancer.
Andrey Federov and Steve Pieper, my fellow main developers of PyRadiomics, thank you for an 
engaging collaboration. I’ll fondly remember all the interesting discussions, both on- and off-
topic, as well as our face-to-face meetings at the 3D Slicer Project week. You’ve helped me to 
grow as a Python software developer. Even though I’ve not received any official education on 
software development, you’ve made me feel appreciated and skilled at Python development.
Het Recteam kan uiteraard niet ontbreken. Vaak hoor je horror verhalen over onderzoeksteams 
waar het vechten is voor je plekje, maar ik had me geen fijner onderzoeksteam dan het 
Recteam kunnen voorstellen. Doenja (ja, je krijgt je 2e alinea in het dankwoord), naast je 
uitstekende begeleiding ben je ook enorm gezellig buiten het werk om. Met plezier denk ik 
terug aan alle etentjes en borrels, zowel in het buitenland op congres, als even na het werk of 
zomaar spontaan. Ik hoop dat ik nog van vele chevice etentjes met jou en Max mag genieten. 
Beste Max, Ik heb intens genoten van je droge humor en alle interessante discussies die we 
hebben gehad, ook al leidden die meer dan eens tot enig zuchten bij Doenja. Miriam, Rianne en 




het recteam. Eerst als WESP-student en later als (beginnend) PhD-student. Met veel plezier 
denk ik terug aan onze kleine hokjes op de universiteit, met de kanker-bank, koffie sterk 
genoeg om door metaal te branden en niet te vergeten prinsessen-tape. Ik vond het erg 
jammer maar begrijpelijk dat jullie in Maastricht bleven om jullie promotie af te maken. 
Gelukkig hebben we zo nu en dan nog een recteam uitje om even bij te kletsen en was Miriam 
de afgelopen 2 jaar ook mijn directe collega in Apeldoorn! Ik hoop ook in de toekomst weer 
met jullie te kunnen samenwerken. Marit, mijn mede pioneer-PhD bij het recteam, 
afdeling Amsterdam. Uiteindelijk liepen onze onderzoeken vrij parallel, maar zeker in het 
begin was het gezellig om samen ons plekje bij het AvL te vinden.
Stefano, initially we worked closely together on AI in rectal cancer, but pretty soon you pursued 
your own research line with AI in immunotherapy! I enjoyed our trips to the United States 
together and learned a lot from you on how to use deep learning. Whenever I had a question, 
you were there to help me along. I hope we continue working together in the future. 
Members of the Geek Room, sometimes it was a tight fit in our office, but always a pleasure! 
We started out with Stefano, Paula and Marjaneh, but lost Stefano to “room 10”… I’ll fondly 
remember all the interesting and funny discussions, internet memes on the wall and many, 
many cups of coffee. Paula, bij je sollicitatiegesprek werd je na je gesprek even in de Geek 
Room geparkeerd, waar je ondanks het feit dat je een tikkeltje zenuwachtig was meteen een 
goede indruk achterliet. Dank voor alle gezelligheid en de groene touch die je hebt aangebracht 
in de Geek Room. Marjaneh, thank you for all the language lessons and fun times! Of course, 
the “Geek Room” was not the only room in the “tuinhuis”. I’d also like to thank all the other 
members of the “tuinhuis” for all the coffee, Sinterklaas celebrations and many, many lunches. 
Niels, niet alleen een latere aanwinst voor de Geek Room, maar ook mijn opvolger en paranimf, 
wat hebben we een gezellige tijd gehad (en hebben we nog steeds). Ik denk nog met veel plezier 
terug aan ESGAR 2018. Samen hebben we toen Dublin een beetje verkend, inclusief enkele 
pubs onder het genot van meerdere pints Guiness. Maar ook in Nederland hebben we al veel 
gezellige feestjes gehad. Bovendien heb je buiten het werk om mij geholpen bij de verbouwing 
van mijn huis. Ik vind het erg fijn dat je mijn paranimf wilde zijn en ik ben vereerd dat ik te zijner 
tijd die rol ook voor jou mag vervullen.
Maud, wat hebben we een hoop meegemaakt sinds we elkaar in het eerste jaar van onze studie 
leerden kennen. Als enigen van ons zotte groepje zijn wij een PhD begonnen, en hebben maar 
meteen de pact gesloten om elkaars paranimf te zijn. Zo doende… Ondanks dat jij tijdens onze 
studie altijd aangaf weer naar het noorden te willen gaan, ben jij degene die in het zonnige 
zuiden is gebleven, wie had dat ooit gedacht. Ik ben ontzettend blij dat ik jou tot mijn vrienden 
mag rekenen en ik kijk uit naar het moment dat het mijn beurt is om jou bij te staan bij de 
verdediging van je thesis.
Ook de stille krachten op de achtergrond kunnen niet ontbreken in dit dankwoord. Jos Slenter, 
hartelijk dank voor alle moeite die je hebt genomen om mij te helpen met de enorme selecties 
van scans die nodig waren om mijn onderzoek te doen. Erik-Jan Rijkhorst, dank je wel voor al 
het vertrouwen dat je hebt in mijn programmeerkunsten. Zonder jouw steun zou het mij niet 
gelukt zijn wat automatisering in te voeren bij het selecteren van al die scans in het AvL.
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Lieve collega’s van het Gelre ziekenhuis, dank voor het warme onthaal in Apeldoorn. Na 4 jaar 
voltijd onderzoek doen twijfelde ik wel een beetje hoe goed de opleiding radiologie zou gaan. 
Maar in het fijn opleidingsklimaat van Apeldoorn was dat geen probleem, ik kon zelfs meteen 
part-time beginnen, zodat ik nog genoeg tijd had om aan mijn promotie te kunnen werken.
Willem, al toen ik aankondigde dat ik ging promoveren en dus een thesis boekje ging maken 
kondigde jij aan dat je het grafisch ontwerp wilde doen. Nu is het dan eindelijk zover, en ligt 
het boekje er dan. Dank je wel voor alle moeite van het ontwerp maken en al mijn ingewikkelde 
tekst te zetten. Ik ben enorm trots op het “ontworpen non-ontwerp” van het resultaat.
Ook de bourgondiërs mogen niet ontbreken in dit dankwoord. Jullie zorgden voor de 
broodnodige afleiding tussen al het harde werken door. Het begon als zeilen en feesten in 
Maastricht tijdens onze studie, maar ondertussen is dat uitgebreid met huizen verbouwen, 
bruiloften en uiteraard het zeilreisje naar Kroatië! Bij de eetclub leven we ons helemaal uit in 
de keuken. Begonnen als een leuk ideetje tijdens het eten bij een introweekend, maar nu jaren 
verder zetten we nog steeds heerlijke 8-gangen diners neer.
Mijn lieve familie, dank je wel voor alle steun door de jaren. Lieve Corry en Jan, zonder jullie 
wijze lessen was ik nooit zo ver gekomen. Lieve Marjoke, Hessel, Arne, Bernd en Miriam, mijn 
broers en zussen, wat hebben we toch veel meegemaakt. Ik ben ontzettend trots op onze 
hechte relatie, ondanks de wat complexe familie samenstelling en leeftijds verschillen. Ons pap 
en mam zijn er helaas niet meer om mijn verdediging bij te wonen, maar ik herken ze in jullie en 
weet dat ze trots zouden zijn op wat wij allemaal bereikt hebben.
Ook mijn nieuwe familie wil ik graag bedanken. Lieve Karen en Marco, wat ben ik blij met jullie 
als schoonouders. Meteen toen ik aankondigde dat ik naar Amsterdam moest verhuizen gaven 
jullie aan dat als het nodig was ik zonodig bij jullie kon bivakeren. Wageningen is een best eind 
van Amsterdam, maar nog altijd beter dan Maastricht. Gelukkig was het niet nodig en kon ik 
op tijd een kamer vinden in Osdorp. Lieve Viv en Bram, samen met Nathalie delen we een 
voorliefde voor speciaalbier. Met jullie erbij is er nooit een saai moment. Daarnaast vinden wij 
verduurzaming allebei heel belangrijk en geniet ik van onze discussies over hoe je je impact op 
het milieu zo klein mogelijk kan houden.
Nathalie, achter elke succesvolle man staat een sterke partner en dat ben jij. Zonder jou 
had ik dit alles zeker niet gered. Zowel in actieve hulp bij het werk, en dan met name door je 
uitstekende planinngs-skills (die bij mij soms wel wat hulp kunnen gebruiken), als ook je mentale 
steun en enorme geduld. Al bij het begin van mijn promotie was je enorm ondersteunend 
en was je zonder discussie bereid onze plannen voor samenwonen in de koelkast te zetten. 
Intussen wonen we al weer ruim 4 jaar samen in Utrecht en kijken we met veel plezier en 
spanning naar onze toekomst samen. Ik had me geen betere levenspartner kunnen voorstellen 
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Joost Johannes Marijn van Griethuysen was born on November 29th 1990 in Casteren, a small 
village in the Kempen, near the Belgium border in Noord-Brabant. After graduating cum laude 
from high school in 2009, he started studying medicine in Maastricht. Throughout his studies, 
Joost had taken a liking to radiology, prompting him to combine his final clinical and scientific 
internship at the radiology department of the MUMC. It was here that he first met with prof. dr. 
Regina Beets-Tan, who proposed this PhD-track as part of a new collaboration between her 
research team and that of prof. dr. Hugo Aerts. After receiving his masters’ degree cum laude 
in 2015, Joost joined prof. dr. Beets-Tan in moving to Amsterdam to work at the Antoni van 
Leeuwenhoek/The Netherlands Cancer Institute, and supplemented his work with several visits 
to Boston to work as part of prof. dr. Aerts’ team.
In December 2019, Joost finished his PhD contract and started his clinical residency at the 
radiology department of Gelre hospital in Apeldoorn on a part-time basis. In the additional 
spare time, Joost continued his research as well as the development of software intended to 
automate key pre-processing steps in the radiology research workflow at The Netherlands 
Cancer Institute.
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